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Thesis abstract 
 
Introduction 
Obesity and diabetes are highly prevalent non-communicable diseases. It has been reported 
that these conditions induce skeletal muscle impairments in terms of structure and function. 
However, the current understanding of these processes is limited, where skeletal muscle 
extracellular matrix remodelling and impairments in its endocrine function during metabolic 
disease are clear examples. Furthermore, physical exercise is one of the most prescribed 
lifestyle modifications to counteract these disturbances, where muscle adiponectin induction 
in an obesity context has gained increasing interest. However, comparisons between different 
exercise modalities on these outcomes are scarce and require further investigation. 
Aims 
This thesis aimed to investigate the metabolic effect of two isocaloric training programs: 
moderate-intensity endurance (END) or high intensity interval training (HIIT), in a mouse 
model of diet-induced obesity using a preventive approach. Moreover, it also compared the 
effects of two isocaloric training programs (END vs HIIT) on the adiponectin profiles in 
exercising and non-exercising muscles with different metabolic features. In a broader aspect, 
it compared the effects of two isocaloric programs (END and HIIT), on the metabolic 
function of skeletal muscle, white adipose tissue, and liver of an established obese mice 
model, using a treatment approach. Finally, it aimed to investigate the effect of long term 
diabetes and obesity on the skeletal muscle extracellular matrix of C57BL/6 mice, along with 
the combination of these two conditions. 
Methods 
Three different animal experiments were designed to achieve the aims of this thesis. First, 72 
male C57BL/6 mice were fed with standard CHOW or high-fat diet for 10 weeks; 
simultaneously they underwent one of two different isocaloric exercise programs, constant-
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moderate (END) or high-intensity interval training (HIIT) for the same 10 weeks (preventive 
approach). At the end of this experiment, quadriceps, gastrocnemius, and masseter muscles, 
along with subcutaneous and epididymal adipose tissue depots and plasma were collected and 
analysed. In the second experiment, another 72 male C57BL/6 mice were fed with standard 
CHOW or high-fat diet (HFD) for 10 weeks; then they underwent END or HIIT for another 
10 weeks to complete 20 weeks of experiment (treatment approach). At the end of this 
experiment, quadriceps muscle, subcutaneous adipose tissue, liver, and plasma were 
collected and analysed. In the third experiment, 51 male C57BL/6 mice were fed with 
standard CHOW or HFD for 15 weeks; then in a subset of each dietary group diabetes was 
induced through low-dose I.P. injections of streptozotocin. Subsequently, dietary intervention 
was continued for another 15 weeks. At the end of this experiment, quadriceps muscle and 
plasma were collected and analysed. 
Results 
When HFD and exercise was initiated simultaneously, both training programs similarly 
protected against body weight gain, preserved lean/fat tissue mass ratio, and improved blood 
glucose excursion during an insulin tolerance test compared to HFD untrained animals. 
Hyperglycaemia and hyperinsulinaemia were prevented only by END. HFD induced an 
increase of low-molecular weight (LMW) adiponectin in gastrocnemius and masseter, and a 
decrease of high-molecular weight (HMW) adiponectin in quadriceps. Only END prevented 
these changes. HFD induced a decrease of adiponectin receptor 1 (AdipoR1) protein in 
exercising muscles (quadriceps and gastrocnemius) of untrained mice; notably, END also 
decreased AdipoR1 protein levels in lean and HFD mice. This type of training also 
normalized HFD-driven mRNA changes found in some adiponectin downstream factors in 
the three muscles tested.  
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In animals already obese and insulin-resistant (treatment approach), neither END nor HIIT 
altered body weight or composition in HFD mice. HIIT but not END improved insulin 
sensitivity in HFD mice. In quadriceps, HFD decreased HMW adiponectin protein, which 
was normalized by END and HIIT. In contrast, HIIT but not END reversed the HFD-driven 
decrease in the AdipoR1. In SAT, both programs tended to decrease collagen VI protein in 
HFD, suggesting lower fibrotic levels and more expandability of this tissue, whereas only 
HIIT induced an increase in the mRNA (3-fold vs HFD untrained) and protein (2-fold vs 
HFD untrained) of UCP1. In liver, only END reversed collagen accumulation seen in HFD 
untrained mice. 
Diabetes and high-fat diet induced-obesity decreased quadriceps weight and grip strength. 
Muscles of diabetic alone mice showed protein increases in growth factors, extracellular 
matrix (ECM) regulators and collagen content. In contrast, HFD alone induced a decrease in 
growth factors, ECM regulators, without changes in its collagen content. Moreover, diabetic 
alone mice exhibited increased caspase expression, whereas HFD alone had an opposite 
effect.  
Conclusions 
Obesity and diabetes induce skeletal muscle impairments, where the former particularly 
affects its ability to produce adiponectin and the latter induces extracellular matrix 
accumulation. Different exercise prescriptions, even when isocaloric, exert differential 
metabolic benefits in high-fat fed mice. END induced greater desirable metabolic benefits in 
a preventive context, whereas HIIT appears to give greater efficacy in already obese and 
insulin-resistant mice. These findings highlight the complexity of obesity and diabetes-
derived impairments in skeletal muscle, along with the specificity of different exercise 
prescriptions regarding metabolic benefits in the context of obesity. Future research should 
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aimed to explore preclinical mechanisms of such differential effects of exercise regimens in 
greater detail and in testing these findings in a clinical setting. 
 
Hypothesis and Aims of this thesis: 
 
Considering the previous comments, the central hypothesis of this thesis is that while obesity 
and diabetes induce metabolic impairments in skeletal muscle including impacts on the 
muscle extracellular matrix, differing exercise prescriptions will induce differential beneficial 
metabolic benefits in animal models of diet-induced obesity including in skeletal muscle. 
 
The specific aims of this thesis are: 
1. To investigate the metabolic effect of two isocaloric training programs: moderate-
intensity endurance (END) or high intensity interval training (HIIT), in a mouse 
model of diet-induced obesity using a preventive approach. 
2. To compare the effects of two isocaloric training programs (END vs HIIT) on 
adiponectin profiles in exercising and non-exercising muscles with different 
metabolic features. 
3. To compare the effects of two isocaloric programs (HIIT and END) on the metabolic 
function of skeletal muscle, white adipose tissue, and liver of an established obese 
mice model, using a treatment approach. 
4. To investigate the effect of long term diabetes and obesity on skeletal muscle 
extracellular matrix of C57BL/6 mice.  A secondary aim was to also explore the 
effects of the combination of these two conditions on skeletal muscle extracellular 
matrix. 
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Thesis Presentation and Overview: 
 
This thesis in its results chapters is presented as a combination of 1 narrative review, 1 
methodological paper, and 4 published/accepted original research papers. The general 
discussion and conclusion follows, and this thesis has 7 chapters in total.  
 
In Chapter 1, an introduction to obesity, diabetes and its derived metabolic impairments is 
provided. Moreover, specific metabolic disruptions in white adipose tissue, liver, and 
especially in skeletal muscle are given, along with the potential benefits of exercise training 
on resolving these disturbances. At the end of this chapter, a published narrative review 
regarding the effects of obesity and exercise on the extracellular matrix of skeletal muscle is 
included. 
 
In Chapter 2, a detailed materials and methods section is provided which includes the 
different study designs, procedures and protocols used throughout the development of this 
thesis. Also, a published paper on the utility and validation of non-invasive muscle function 
tests is included in this chapter, given its relevance for characterising obesity-related muscle 
dysfunction in the animal models used in this thesis. 
 
In Chapter 3 a published paper is presented showing the differential metabolic effects of two 
isocaloric exercise programs, namely constant-moderate endurance (END) and high-intensity 
interval training (HIIT) on high-fat fed mice. Here, the dysregulation and potential role of 
muscle adiponectin induction regulating these metabolic differences is discussed (aim 1). It is 
notable that in this chapter; a preventive approach was undertaken in the study design. 
Consecutively, in chapter 4 a follow-up paper is presented where, from the same animals as 
the previous chapter, the differences in skeletal muscle adiponectin profiles across three 
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different muscles are described (aim 2). Here, the influence of diet, exercise and muscle 
type/activity on muscle adiponectin induction along with its possible metabolic benefits are 
discussed. 
 
Progressing from the findings in Chapters 3 and 4, a submitted paper is presented in Chapter 
5, where differential metabolic benefits of END and HIIT in high-fat fed mice were further 
explored. In this case a treatment approach was considered, meaning that the animals were 
already obese prior to exercise training. Here, exercise effects on white adipose tissue, liver, 
and skeletal muscle were investigated in order to clarify if different exercise programs, even 
isocaloric, induced tissue-specific benefits independent of changes in body weight and/or 
body composition (aims 1 and 3). 
 
In Chapter 6, a submitted paper is presented where the impact of diabetes and obesity on 
skeletal muscle structure, particularly on the extracellular matrix and regulators was 
investigated. The eventual mechanisms behind this differential impact are also explored (aim 
4). 
 
Finally, Chapter 7 provides an integrated scholarly discussion regarding the research topics 
investigated in this thesis, along with the novel findings and, in conclusion, possible future 
directions derived from this work. 
23 
 
Chapter 1 
Literature review 
 
1.1 Obesity, insulin resistance, and diabetes 
 
Obesity is defined as abnormal or excessive fat accumulation that may impair health; obesity 
affects 650 million adults worldwide (WHO, 2017). In terms of morbidity around 50% of 
people with diabetes are obese, they are 3.5 times more likely to have hypertension, whereas 
economically speaking obesity accounts for 2.3 to 2.6% of total public health spending in the 
UK (Abdelaal et al., 2017). In Australia, the Australian Institute of Health and Welfare 
estimated that between 2014-2015, 28% of adults were considered to be obese,  a figure 
which represented a 19% increase compared with 1995 (AIHW, 2018).  
 
One of the most common consequences of excess energy intake is the development of 
hyperglycaemia, defined as elevated levels of glucose in blood to predefined pathological 
ranges; in Australia, diabetes is diagnosed when fasting glucose measurements are at or 
above 7.0 mmol/L, and/or random blood glucose measurements above 11.1 mmol/L. In 
asymptomatic individuals two diabetes range results on 2 separate days are required. Also as 
per the WHO, in recent years a HbA1c level ≥6.5% NGSP units can also be used to diagnose 
diabetes mellitus (d'Emden et al., 2012). This is because, in normal conditions, blood glucose 
values are tightly regulated by glucose and related metabolite negative feedback on insulin 
release from the pancreatic β-cells, and insulin promotes glucose intake in insulin-sensitive 
tissues such as adipose tissue, liver and skeletal muscle  (Kahn et al., 2006). During obesity, 
insulin resistance commonly occurs where insulin-sensitive tissues respond less well to 
insulin stimulation, with consequent secondary increased levels of insulin secretion and 
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chronic hyperinsulinaemia. In susceptible individuals, secondary to excessive insulin 
production and secretion, pancreatic β-cells become dysfunctional exhibiting a lack of insulin 
production and release, resulting in chronic hyperglycaemia, into the levels of pre-diabetes 
or, in more severe hyperglycaemia, to type 2-diabetes (Kahn et al., 2006).  
 
Considering that hyperglycaemia has toxic effects (Kawahito et al., 2009), insulin-sensitive 
tissues play a key role in regulating glucose uptake from the circulation, not just to provide 
energy for the cells and tissues of uptake, but to prevent adverse consequences on an 
organism through elevated blood glucose. As previously described, links of obesity to insulin 
resistance, hyperinsulinaemia and then to hyperglycaemia, with related mechanisms, are a 
broad field of scientific research. Furthermore, the development of efficient strategies to 
counteract obesity induced metabolic and pathogenic disturbances are urgently required, in 
order to prevent and treat the metabolic impairments that these diseases cause. 
 
Overall, obesity induces several metabolic impairments that act in a synergistic pattern across 
adipose tissue, liver and skeletal muscle, promoting a decreased response to the action of 
insulin. These changes deeply disturb systemic glucose and lipid homeostasis, and strategies 
that aim to prevent and/or reverse these changes are required to revert to and/or maintain 
health. 
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1.2  Tissue-specific obesity-related impairments 
 
1.2.1 White adipose tissue  
Insulin-sensitive tissues, by taking up glucose from the circulation, regulate glycaemia during 
periods of energy intake and in a basal, fasting state. The main energy reservoir in the human 
body is adipose tissue, where glucose is stored mainly as triacylglycerols (TAGs) through a 
process called lipogenesis, which is mainly controlled by insulin. Broadly, adipose tissue can 
be either white or brown in type  (Tchkonia et al., 2013). Brown adipose tissue is composed 
of cells with high mitochondrial content, where one of its major functions is to dissipate 
energy excess into heat (Seale and Lazar, 2009). In contrast, white adipose tissue is 
composed of adipocytes with low levels of mitochondria and single lipid droplets, where its 
most important functions are to store energy in the form of TAGs and its intermediates (e.g. 
diacylglycerols, ceramides), along with the secretion of mediators (adipokines) into the 
circulation or in an autocrine/paracrine manner (Kwon and Pessin, 2013). The most prevalent 
adipokine is adiponectin, which represents around 0.01% of all the protein content in the 
circulation. Adiponectin acts through its receptors (AdipoR) 1 and 2, and it has several 
metabolic functions such as the stimulation of fatty acid oxidation and enhancing insulin 
sensitivity (Rosen and Spiegelman, 2006). Moreover, it has been recognized that some cells 
in white adipose tissue can acquire brown adipocyte characteristics (called brite or beige 
adipocytes), with higher levels of mitochondria and multilocular fat depots. This process is 
called beiging or browning (Tchkonia et al., 2013), and it is thought to be induced by 
physiological stimuli such as cold exposure, or exercise (Stanford et al., 2015a, Dempersmier 
et al., 2015). 
Normally, in order to increase its area and therefore its storage capacity, white adipose tissue 
has the ability to expand due to hyperplastic and hypertrophic processes (Jo et al., 2009). One 
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of the mechanisms behind this plasticity, is the considerable number of precursor cells 
(preadipocytes) present in mature white adipose tissue, which ranges from 15 to 50% of cells 
(Tchkonia et al., 2013). However, during obesity adipose tissue commonly becomes 
dysfunctional, and through several mechanisms such as: disruption of its endocrine function, 
macrophage infiltration and inflammation, and extracellular matrix accumulation and fibrosis 
(Prakash et al., 2013, Spencer et al., 2010, Sun et al., 2013).  
 
The extracellular matrix (ECM) in adipose tissue plays a key physiological role in allowing 
structural changes in adipose tissue to occur when higher levels of energy storage are needed 
(Mariman and Wang, 2010). Progressively however, in obese subjects it has been described 
that adipose tissue ECM accumulates showing fibrotic features, impairing its expandability 
(Spencer et al., 2010). Consequently, adipose tissue undergoes hypoxia and inflammatory 
cells infiltrate this tissue (Engin, 2017), inducing the production and release of pro-
inflammatory mediators, such as monocyte chemotactic protein-1 (MCP-1), interleukin-6 
(IL-6), and tumor necrotic factor (TNF) (Sun et al., 2013). For example, mRNA levels of 
adipose tissue collagen VI (COL6) are positively correlated with body mass index (BMI) in 
humans, and higher levels of COL6 were found in people with higher visceral and MCP-1 
mRNA levels. Moreover, eight weeks of overfeeding induced similar effects in humans 
(Pasarica et al., 2009), suggesting the high relevance of ECM accumulation and the 
subsequent inflammation in the development of adipose tissue dysfunction during obesity, 
which are characteristics described by several research groups (Mariman and Wang, 2010, 
Pasarica et al., 2009, Spencer et al., 2010, Sun et al., 2013). 
 
Mitochondrial function in white adipose tissue is responsible for >95% of ATP production 
(Cedikova et al., 2016), the latter which is necessary for TAGs synthesis and release of 
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adipokines. During obesity, it has been proposed that mitochondrial function is reduced 
(Rong et al., 2007). Yin et al. measured mitochondrial function in omental and subcutaneous 
fat depots in humans, finding that tissue protein levels of citrate synthase and oxygen 
consumption rates of isolated mitochondria were lower in obese patients compared to lean 
controls (Yin et al., 2014). Moreover, another feature related to mitochondrial function is the 
presence of brown adipocytes in white adipose tissue, which can be used to expend energy 
excess in the form of heat, a phenomenon that could be beneficial in an obesity context 
(Kiefer, 2017). A key protein in this process is uncoupling protein 1 (UCP-1), present in 
brown adipocytes and responsible of the proton motion dissipation that is normally used to 
produce ATP in the mitochondria, and, consequently, the electrochemical gradient energy is 
released in the form of heat (Seale and Lazar, 2009). In animal models of obesity, particularly 
in high fat diet fed mice, it has been described that the presence of these beige adipocytes and 
UCP-1 content is relatively decreased (Wang et al., 2017, Fromme and Klingenspor, 2011), 
suggesting that obesity disrupts this feature, further predisposing this tissue to continue its 
expansion rather than its dissipation.  
 
Physical exercise has been described as an effective strategy to counteract obesity-related 
white adipose tissue disturbances; normalization of adipocyte size, mitochondrial activity and 
induction of browning, along with ECM regulation (Lehnig and Stanford, 2018). For 
example, after a 15-weeks of dietary and exercise intervention, subcutaneous adipose tissue 
of severely obese patients exhibits lower levels of macrophage infiltration and mRNA levels 
of inflammatory markers such as IL-6, IL-8, and TNF-ɑ; these changes corresponded with 
decreases in circulatory markers of low-grade inflammation and with improved glucose 
tolerance (Bruun et al., 2006). In preclinical studies, similar results have been reported in 
diet-induced obese mice, where 6 weeks of voluntary exercise performed in running wheels 
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were enough to decrease mRNA levels of inflammatory mediators in white adipose tissue 
(perigonadal), such as Tnf and Mcp-1 (Bradley et al., 2008). Considering that inflammation is 
one of the hallmarks of dysfunctional adipose tissue during obesity and may be one of the 
precursors of the structural remodelling in terms of ECM accumulation (Pasarica et al., 2009, 
Sun et al., 2013), it is plausible to argue that exercise could also prevent or reverse adipose 
tissue ECM accumulation during obesity - however, there have been few studies in this area. 
Also, it has been suggested that exercise is able to increase white adipose tissue 
mitochondrial function (Trevellin et al., 2014) and to induce browning (Stanford et al., 
2015a). For example, after 30 days of swimming training, C57BL/6 mice showed higher 
mRNA and protein levels of peroxisome proliferator-activated receptor gamma coactivator 1-
alpha (PGC-1ɑ), a well-known mediator of mitochondrial function along with higher levels 
of mitochondrial DNA in subcutaneous adipose tissue (SAT) (Trevellin et al., 2014). In 
contrast, increases in the number of beige adipocytes as an effect of exercise training has 
been reported in mice after 11 days of voluntary exercise in running wheels. These changes 
were accompanied by increases in the transcription and translation of UCP-1 along with 
higher rates of oxygen consumption in trained mice compared with sedentary controls 
(Stanford et al., 2015b). These effects have not been explored in animals fed with high-fat 
diet and/or with different exercise protocols. Moreover, the evidence of browning in humans 
in less clear (Norheim et al., 2014, Ronn et al., 2014, Tsiloulis and Watt, 2015), therefore 
further studies in this topic are required in order to elucidate potential therapeutic effects of 
exercise on white adipose tissue metabolism during obesity. 
 
1.2.2 Liver 
Another common consequence of obesity, and particularly ectopic fat deposition, is the 
development of non-alcoholic fatty liver disease (NAFLD). NAFLD is defined as fat 
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infiltration in at least 5% of total liver, especially in hepatocytes (Williams et al., 2013). 
NAFLD is present in ~30-40% of men and in 15-20% of women (Byrne and Targher, 2015), 
making it a significant obesity-related metabolic burden.  
 
Under normal conditions, the liver is able to store TAGs, which are mainly from TAGs 
degradation in white adipose tissue depots through lipolysis, dietary consumption of free fatty 
acids (FFA), and from de novo lipogenesis (Gan et al., 2015). During obesity, TAGs storage 
is chronically increased. Moreover, increases in metabolic intermediates, such as 
diacylglycerols (DAGs) and ceramides are seen in persons with obesity which are thought to 
have a negative impact on liver metabolic function (Asrih and Jornayvaz, 2013). There are 
several markers used to assess the magnitude of liver damage, such as plasma measurements 
of liver enzymes of alanine transaminase (ALT), aspartate transaminase (AST), gamma 
glutamyltransferase (GGT), and alkaline phosphatase (ALP). The blood levels of these 
enzymes, especially the ALT and GGT, are often increased in NAFLD secondary to 
hepatocyte damage and consequent release of these enzymes to the circulation (Limdi and 
Hyde, 2003). Unfortunately, changes in the plasma levels of these proteins are not highly 
sensitive nor are they specific markers of liver damage caused by excessive liver fat 
infiltration, therefore, the direct study of liver morphology and function remains the gold 
standard in NAFLD (Ban et al., 2016).  
 
Excessive fat accumulation can induce liver damage and dysfunction through several 
mechanisms, including inflammation and fibrosis in its more severe presentation (Lo et al., 
2011, Williams et al., 2013), known as non-alcoholic steatohepatitis (NASH) (Moore, 2010). 
The interaction of these processes is still unclear, however, one of the hypothesis indicates 
that excess in fatty acid influx could induce an inflammatory response from hepatocytes, as a 
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stress response, which in the case of obesity is usually maintained through time, inducing the 
production of growth factors, such as CCN2/CTGF and TGFβ, which, in turn, promotes 
collagen production, extracellular matrix accumulation and fibrosis (Lo et al., 2011). On top 
of this, mitochondrial dysfunction usually develops during obesity in the liver, impairing fatty 
acid oxidation, promoting excess of lipid storage (Wei et al., 2008). Moreover, it has been 
proposed that the progression from the low-grade inflammatory phenotype of simple steatosis 
in NAFLD, to the more marked pathology of hepatocyte damage with ballooning, 
inflammation and pro-fibrotic changes (NASH phenotype with accumulation of collagens, 
particularly type I and IV) are mediated by key pro-inflammatory factors such as TNF, IL-6, 
infiltration of inflammatory cells such as macrophages, and the more recently described 
interferon gamma-induced protein 10 (Cxcl10) (Zhang et al., 2014), which are potentiated by 
adipokines such as TNF, and IL-6 (Tilg and Moschen, 2010). From a mechanistic point of 
view, this might be related to the presence of growth factors that regulate the liver ECM, such 
as transforming growth factor β (TGFβ) (Holmes, 2017). The relevance of this growth factor 
resides in that recently, in mice fed with HFD for 40 weeks, decreases in fibrotic markers 
were seen when a group of those animals were treated with an anti-TGFβ antibody for the last 
4 weeks of dietary intervention. Results that were replicated in interferon γ KO mice, where 
NASH developed faster, milder fibrotic features were seen in a subgroup of this animals 
treated with the anti-TGFβ antibody (Hart et al., 2017). Therefore, the study of ECM 
regulators, constituents (collagens), along with inflammation markers, are required to fully 
characterise the metabolic disturbances associated with NAFLD. In this context, our 
laboratory in Lo et al. characterized the liver changes associated with high-fat diet and 
hyperglycaemia in a mouse model of NAFLD, finding that in that time limited model, HFD 
alone induced the development of NASH features such as elevated intrahepatic lipids and 
macrophage infiltration, without signs of fibrosis in terms of collagen accumulation. 
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Nevertheless, hyperglycaemic and thus diabetic mice with HFD mice showed signs of 
elevated collagen mRNA (-I, and -III) and protein (-I) plus increases in growth factors, 
particularly connective tissue growth factor (CTGF/CCN2) (Lo et al., 2011), suggesting that 
serial insults are required to progress from a classical NAFLD to a more aggressive NASH 
phenotype. Consequently, strategies that aim to prevent/reverse these metabolic disturbances 
should take into consideration their effectiveness in reducing liver inflammation 
mediators/markers, along with normalization of liver ECM regulators and constituents.  
 
Exercise has been proposed as a non-invasive strategy to counteract NAFLD development 
and its associated metabolic disturbances (van der Windt et al., 2017). Indeed, clinical and 
preclinical studies have helped to build a body of evidence to support this argument. Early 
studies with animals described promising exercise-derived effects on liver metabolism, such 
as landmark early reports where lower levels of liver TAGs were observed in male Wistar 
rats after running in a treadmill until exhaustion (Gorski et al., 1988), suggesting potent acute 
effects of exercise on liver TAGs availability. More recently, through the study of livers from 
rats susceptible to develop NASH through HFD (OLETF), 12 weeks of constant-moderate 
endurance exercise (60 minutes per day/5 days per week) reduced markers of fibrosis, 
including lower collagen-I mRNA levels and less trichrome positive staining scores 
(indicative of collagen accumulation) from liver histological slides (Linden et al., 2016). 
Moreover, 4 weeks of constant-moderate endurance exercise in HFD C57BL/6 mice (30 to 60 
min a day/5 days per week) induced dramatic changes in the liver lipidome by reducing the 
presence of different species of TAGs, DAGs, and ceramides, along with decreases in 
proteins related to lipid entry in livers such as cluster of differentiation 36 (CD36) and fatty 
acid transport protein 4 (FATP4) (Jordy et al., 2015), suggesting that exercise not only 
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decreases the level of TAGs and its intermediates, but also regulates lipid entry in the liver, 
thus protecting it from excessive fat infiltration.  
 
The effects of different exercise protocols including type, intensity, duration and repeatability 
on liver metabolism in an obesity context are less clear. For instance, Cho et al. described 
greater metabolic protection in the liver from high-intensity protocols, such as high-intensity 
interval training (HIIT) compared to constant-moderate endurance training (END) in high-fat 
diet fed C57BL/6 mice where, after 8 weeks of training, HIIT was more successful at 
normalizing AdipoR2 receptor levels, phosphorylated 5' AMP-activated protein kinase 
(pAMPK)/AMPK, and phosphorylated Acetyl-CoA carboxylase (pACC)/ACC ratios, 
suggesting a higher time-efficiency of this training program to obtain similar metabolic 
benefits compared to END (Cho et al., 2015). Similarly, results described in high-fat diet fed 
ICR mice where HIIT was more effective in reducing body weight, fat mass, and preventing 
increases of mRNA of genes associated with hepatic lipogenesis (Sterol regulatory element-
binding transcription factor 1 (SREBP1), ACC1, fatty acid synthase (FAS)) after 8 weeks of 
training (5 days per week) (Wang et al., 2017). In these reports, neither of the HIIT exercise 
regimens were isocaloric to the END regimens.  Despite these studies supporting that HIIT is 
a more effective program to prevent/reverse NAFLD phenotype in animal models of obesity 
(Linden et al., 2015), striking evidence in humans shows that energy-matched (isocaloric) 
HIIT and END programs confer similar liver metabolic benefits in overweight/obese patients 
after 4 weeks of training. This is because both training programs induced similar 
improvements in intrahepatic fat and lipid peroxidation levels without any changes in body 
weight or body composition (Winn et al., 2018). These findings suggest that when exercise 
programs are isocaloric, they are similarly able to reverse liver fat deposition and tissue 
damage derived from obesity. Consequently, the comparison of isocaloric protocols on liver 
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metabolism during obesity are needed in order to properly elucidate if there are differential 
benefits from different exercise modalities. 
 
1.2.3 Skeletal muscle 
Skeletal muscle is a highly adaptive and dynamic tissue. Its function is to produce force and 
movement through its connections to bones and joints and it has a highly specialized 
architecture to achieve this. Actin-myosin complexes are aligned proximate to each other in 
order to co-ordinately contract and produce force, which is appropriately transmitted to the 
extracellular matrix, tendons and joints to finally produce movement. Muscles differ from 
each other depending on their respective mechanical and metabolic function. For instance, 
muscles where the activity is required for long periods of time (e.g. postural or breathing 
muscles) are composed of fibres that are resistant to fatigue, termed type I fibres. The major 
characteristics of type I fibres are their small size, large number of mitochondria and their 
larger vascular supply (Lieber, 2010). These features predispose them to rely on aerobic 
mechanisms to produce energy (i.e. oxidative phosphorylation). In contrast, muscles that are 
responsible for generating larger amounts of force for shorter periods of time (e.g. muscles 
involved in sprinting like gastrocnemius) are composed by fatigable fibres, termed type II 
fibres. They are larger than type I fibres, with less mitochondria and vascular supply, 
however, they produce larger amounts of force at a higher velocity. To achieve this, they rely 
on anaerobic pathways to produce energy (i.e. glycolysis) (Lieber, 2010). There are three 
different subtypes of type II fibres, from more aerobic to more anaerobic termed Type IIA, 
Type IIX, and Type IID fibres. These features give skeletal muscles plasticity to adapt to 
different levels of mechanical load and usage, increasing their size and force production when 
anaerobic efforts are produced chronically through time (e.g. resistance training), or 
increasing in the ability to resist fatigue when chronic long-lasting effort are produced (e.g. 
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running during long distances). Also, decreases in maximal force and increases in fatigability 
have been described when muscle activity is chronically decreased (e.g. sedentary states, 
immobilization, denervation) (Lieber, 2010).  
 
In recent decades, the molecular mechanisms responsible of skeletal muscle contraction, 
along with the processes related to energy production (anaerobic and aerobic) and 
morphological fibre subtype, have been heavily investigated and described (Matusovsky et 
al., 2015, Lieber, 2010, Sweeney and Hammers, 2018) across different physiological states 
along with the effects of pathological metabolic disturbances such as obesity and diabetes.  
 
1.2.4 Skeletal muscle dysfunction in obesity 
Obesity induces muscle dysfunction, which is characterized by a decreased ability to produce 
force and to sustain fatigue (Hasan et al., 2016, Rastelli et al., 2015, Tomlinson et al., 2014). 
In this context, Hulens et al. compared grip strength and isokinetic (contractions at a steady 
velocity) leg and trunk strength in lean and obese women. They found that obese women had 
lower hand grip and leg isokinetic strength than lean controls, however, surprisingly in terms 
of trunk strength, obese women had a higher performance (Hulens et al., 2001). This was 
explained by the mechanical overload associated with a larger body mass.  
Complementarily, Maffiuletti et al. described similar impairments in obese adults in terms of 
lower quadriceps muscle strength and power performances, moreover, obese participants 
exhibit higher quadriceps fatigability compared to lean peers (Maffiuletti et al., 2007), 
findings that confirm that obesity-related muscle impairments impact not only maximal but 
also submaximal strength performances. Similar findings have been described in high-fat diet 
fed mice where maximal and submaximal muscle strength performances are lower than 
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chow-fed mice after 10 and 20 weeks of dietary intervention (Martinez-Huenchullan et al., 
2017b). 
Tomlinson et al. explored if obesity-related muscle dysfunction affected the muscle as a 
whole or whether obesity impaired the smaller subunit of this tissue like muscle fascicles. In 
that study, gastrocnemius medialis volume and muscles fascicles were detected through 
ultrasonography and ultrasound scanning respectively, while fascicle strength was also 
obtained indirectly through mathematical calculations. Muscle strength in obese women, 
when normalized by muscle volume and fascicle strength, was 26% and 34% lower than in 
lean participants (Tomlinson et al., 2014), proposing that muscle dysfunction can be detected 
at the fascicle level as well. Higher levels of fat infiltration in muscle and higher pennation 
angles (angulation between muscle fascicles and its respective tendon) in quadriceps muscles 
were found in obese women compared with lean counterparts, findings that were correlated 
with lesser muscle strength (Rastelli et al., 2015). These findings relate muscle architecture 
impairments as consequences in obesity to muscle dysfunction. Similar results were reported 
in patients with type 2 diabetes where higher levels of fat infiltration and lower strength and 
power in calf muscles were observed (gastrocnemius and soleus) (Hilton et al., 2008). 
 
1.2.5 The effect of type 2 diabetes on skeletal muscle structural and functional changes  
As a progression of obesity and insulin resistance, the mechanical and metabolic effects of 
type 2 diabetes in skeletal muscle have become a growing scientific field in the last couple 
decades. Early studies were focused on characterising the muscle performance and mass in 
patients with type 2 diabetes, finding that muscle groups from the ankle and knee exhibit 
lower muscle strength compared to their healthy counterparts, a finding that was exacerbated 
in the presence of diabetes complications (e.g. neuropathy) (Andersen et al., 2004). 
Moreover, earlier decreases in muscle mass have been reported in older adults with type 2 
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diabetes (Guerrero et al., 2016), adding a structural consequence of type 2 diabetes on 
skeletal muscle physiology.  
As expected, subsequent studies began to investigate the underlying mechanisms of these 
physiological and clinical changes. To date, one of the main findings indicates that muscle 
from patients with type 2 diabetes exhibit lower levels of metabolic flexibility. This means 
that under different physiological states (e.g. fasting vs insulin-stimulation) skeletal muscles 
lose their ability to switch from fatty acid to glucose oxidation, and vice versa (Phielix and 
Mensink, 2008), suggesting that both mechanisms (lipids and glucose oxidation) are affected 
by this condition. In this context, previously described changes that occur during obesity (e.g. 
muscle inflammation, oxidative stress) are exacerbated in patients with type 2 diabetes, which 
further dysregulates glucose transporters function, such as GLUT4 (Alvim et al., 2015). 
Complementarily, skeletal muscle mitochondrial dysfunction is a common finding in people 
with type 2 diabetes (Fujimaki and Kuwabara, 2017), a change that decreases the ability of 
this tissue to oxidise fatty acids to produce energy, therefore promoting a further 
accumulation of lipids in this tissue, perpetuating the metabolic disturbances derived from 
this condition (Aguer and Harper, 2012). The results from these studies, suggest that 
metabolic flexibility is heavily impaired in type 2 diabetes, whereas during obesity, this 
feature is closer to normal conditions and may be able to be more readily normalised in 
obesity compared with diabetes. 
Interestingly, higher levels of physical activity and interventions based on physical exercise 
have proven to be effective in reversing, at least partially, the development of metabolic 
inflexibility (Ghaderpanahi et al., 2011, Sigal et al., 2006). Mechanisms behind this 
improvement could be associated with exercise-related increases in fatty acid oxidation levels 
(van Loon et al., 2001), mitochondrial function and quantity (Trevellin et al., 2014), and 
glucose mobilization to skeletal muscle cell (Richter and Hargreaves, 2013). However, 
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considering the variability of exercise programs that exists along with the specific metabolic 
benefits that each of them confer, the establishment of the most effective exercise 
prescription in a metabolic dysfunction context remains elusive.  
 
1.2.6 Glucose metabolism in skeletal muscle: effects of obesity 
In addition to skeletal muscle important isokinetic and durability mechanical properties, it 
also plays a key metabolic role in terms of glucose uptake and insulin sensitivity in humans 
(Richter et al., 1989). The metabolic effects are related to glucose transporter availability in 
the skeletal muscle membrane (Richter and Hargreaves, 2013), along with the action of 
insulin on this tissue (Hawley and Lessard, 2008). From a glucose uptake perspective, 
increases in muscle activity (i.e. exercise) increase blood supply by capillary dilation along 
with angiogenesis after chronic exercise training (Sacre et al., 2015, Wagenmakers et al., 
2016). Additionally, GLUT4 transporters which are prevalent in skeletal muscles, are 
translocated from the cytoplasm to the membrane by pathways that are dependent on the 
action of guanosine triphosphatases-activating proteins (GAPs). In GAP4 knockout mice, 
GLUT4 protein levels are decreased by ~40% in quadriceps, tibialis anterior and extensor 
digitalis longus muscles, along with impaired exercise tolerance (Stockli et al., 2015). Once 
inside the muscle cell, hexokinases -1 and -2 as the most prevalent isoforms in skeletal 
muscle, phosphorylate glucose, keeping it inside the cytoplasm (Lark et al., 2012). Along 
with these proteins, mitogen-activated protein (MAP) kinases, actin cytoskeleton, and 
reactive oxygen species have been associated with GLUT4 trafficking in skeletal muscles 
during exercise (Richter and Hargreaves, 2013). MAP kinase activation through insulin 
promotes the activation and translocation of GLUT4 to the muscle cell membrane (Somwar 
et al., 2001). Proper maintenance of the actin cytoskeleton in skeletal muscle seems to be 
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needed for GLUT4 function given that, in muscles from insulin-resistant Zucker fatty rats, 
disruptions in the F-actin structure were seen, changes that were accompanied by GLUT4 
dysfunction (McCarthy et al., 2006). Reactive oxygen species can have a dual effect on 
GLUT4 function, given that in a physiological range GLUT4 can promote its translocation 
through activation of AMPK-dependent signalling (Katz, 2016). However, during obesity, 
where these species are chronically increased, GLUT4 impairments have been described (Di 
Meo et al., 2017). At the same time, exercise also influences insulin signalling. The proposed 
pathways for these effects surprisingly seem not to be dependent on increases in the protein 
expression of the docking proteins insulin-receptor substrates (IRS) -1 and/or -2, but in the 
more downstream phosphorylation of phosphor-inositol-3 kinase (PI3K), that promotes the 
further downstream activation of protein kinase B (Akt), that then consequently further 
promotes the translocation of GLUT4 transporter to the skeletal muscle membrane (Hawley 
and Lessard, 2008). Furthermore, the activation of AMP-activated protein kinase (AMPK) is 
another possible mechanism by which exercise facilitates glucose uptake in skeletal muscles, 
considering the positive influence of AMPK on GLUT4 translocation (O'Neill, 2013). 
 
During obesity, skeletal muscle changes are characterised by lipid infiltration. Early studies 
from Goodpaster et al. identified higher triglyceride deposition in vastus lateralis muscles 
from obese participants in comparison to lean counterparts, and interestingly, this fat 
deposition was most high in obese participants that were also insulin resistant (Goodpaster et 
al., 2000). Given these findings, several studies have attempted to elucidate the possible 
mechanisms behind the association between increased intramuscular fat deposition, with 
insulin resistance and glucose intolerance (Watt and Hoy, 2012). Specific lipid species 
accumulation, inflammation, excess production of oxygen reactive species, and alterations in 
hexokinase activity, have been suggested as possible mechanisms (Lark et al., 2012). 
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Specifically, diacylglycerols and ceramides have been identified as key mediators in 
regulating insulin resistance in obesity and diabetes, where one of the proposed mechanisms 
is that the accumulation intramyocellular DAGs activates protein kinase C, which in turn 
inhibits activities of PI3K and insulin soluble receptor 1 (ISR-1), decreasing the sensitivity to 
the action of insulin in muscle (Kitessa and Abeywardena, 2016). However, the field has 
move to a more specific approach trying to recognise specific lipid species responsible for 
insulin resistance. In this context, lipidomic studies performed in in vastus lateralis of 
overweight/obese participants with and without insulin resistance have found that higher 
levels of muscle ceramides 18:0 (a sphingolipid subtype) were associated with the presence 
of insulin resistance during obesity (Tonks et al., 2016). This suggests that not only the 
amount but also the type of lipids present in skeletal muscle contribute to the development of 
insulin resistance. Lipid infiltration also promotes metabolic disturbances in skeletal muscles 
by inducing a pro-inflammatory state, where in contrast to the lean scenario, intramuscular 
adipose tissue is infiltrated by pro-inflammatory cells (e.g. M1 macrophages, and T-cells) 
which produce inflammatory cytokines, such as TNF and MCP-1, inducing muscle cells to 
further produce a similar set of inflammatory cytokines, promoting chronic muscle 
inflammation (Wu and Ballantyne, 2017). Simultaneously, increases in the production of 
reactive oxygen species (ROS) are present in skeletal muscle, where excess free fatty acid 
(FFA) availability, along with the presence of pro-inflammatory cytokines promotes an 
overactivity in the mitochondria, increasing ROS as a by-product (Di Meo et al., 2017). This 
occurs particularly because of increments in the activity of nicotinamide adenine dinucleotide 
phosphate (NAPDH) oxidase, an enzyme that produces superoxide by reacting with oxygen 
(Hurrle and Hsu, 2017), as seen in muscle cells treated with palmitate (Lambertucci et al., 
2008). Altogether, excess lipid availability, inflammation, and oxidative stress inhibits 
GLUT4 translocation to the membrane, along with inhibitions of insulin receptor substrates, 
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key for insulin signalling, inducing muscle insulin resistance (Hurrle and Hsu, 2017, Brons 
and Grunnet, 2017). Moreover, disturbances in hexokinase activity have been reported in 
soleus muscles of Zucker obese rats, where the expected increase in activity by insulin was 
depressed in rats compared to lean peers (Sanderson et al., 1996), potentiating glucose 
metabolism impairments in skeletal muscle during obesity, given the required hexokinase 
activity (by phosphorylating glucose after its entrance to the muscle cell membrane) for the 
proper glucose transportation into the muscle cell (Lark et al., 2012). 
 
1.2.7 Endocrine functions of skeletal muscle 
A recently emerging function of muscle is the ability of skeletal muscle to produce mediators 
(myokines) that can have an endocrine or an autocrine/paracrine action (Pedersen, 2013). The 
first study that demonstrated this secretory feature of muscles was published in 2000, where 
six healthy males performed one leg knee extensions at 40% of peak power output for 5 
hours, whereas the resting leg acted as a control. As a result, 19-fold systemic increases in 
arterial interleukin-6 (IL-6) after exercise occurred, with on isolated limb sampling, a similar 
net IL-6 release in the exercising leg without changes in the resting leg, suggesting that the 
circulatory increase of this protein was exercise dependent and due to muscle production and 
secretion (Steensberg et al., 2000). In this context, recent efforts have been focused on 
characterising the secretome (Weigert et al., 2014) or myokinome (Whitham and Febbraio, 
2016) of skeletal muscles during exercise, in order to identify potential therapeutic strategies 
and in optimization of exercise regimens. This is a complex challenge given more than 
10,000 proteins can be identified in skeletal muscles after exercise, whereas more than 9,000 
can be found in the circulation during post-exercise periods (Whitham and Febbraio, 2016), 
which suggest that the variety of proteins that could be considered myokines, is large. Further 
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validation is required in order to confirm which myokines are predominantly muscle-
produced/secreted. It has recently been proposed that series of myokines might have 
important more local metabolic roles in skeletal muscle, by regulating glucose uptake and 
availability through autocrine/paracrine mechanisms, as well as through endocrine signalling 
in communicating with other tissues that regulate carbohydrates and lipid availability in the 
circulation, such as adipose tissue and liver (Pedersen, 2013).  
In particular, some myokines have received more scientific attention given its potential 
metabolic functions. For instance, increases in fibroblast growth factor 21 (FGF21) have been 
reported in mice and humans as an acute response to exercise  with data indicating muscle 
synthesis (Kim et al., 2013), suggesting FGF21 is a myokine. From a metabolic point of 
view, FGF21 has functions in increasing lipolysis in adipose tissue and fatty acid oxidation in 
the liver (Fisher et al., 2010). Another recently described myokine is musclin, which has been 
reported to be a regulator of exercise tolerance in mice. Specifically, in animals lacking the 
gene (Ostn) that encodes musclin, profound decreases in exercise tolerance were seen, 
changes that were associated with decreases in peroxisome proliferator-activated receptor 
gamma coactivator 1-α (PGC-1α) in skeletal muscles after exposure to exercise (Subbotina et 
al., 2015), such findings highlight the potential influence of this myokine in exercise-derived 
metabolic adaptations. Moreover, myonectin is a myokine sensitive to the actions of HFD 
and exercise (reduction and restoration respectively) (Seldin et al., 2012). It is a regulator of 
lipid homeostasis given its ability to stimulate fatty acid uptake from adipocytes and 
hepatocytes, however the exact mechanisms are still unclear (Seldin et al., 2012). 
Therefore, the study of myokines in metabolic disorders has been an active scientific area in 
recent years, with increasing recognition of paracrine and autocrine mediated effects as well 
as endocrine signalling.  
 
42 
 
1.2.8 Muscle adiponectin 
A myokine that has received relatively scientific attention in the last decade is adiponectin. 
From a structural perspective, adiponectin is a 30kDa protein with a carboxyl-terminal 
globular domain and an amino-terminal collagen domain, which enables it to form multimers 
(Pajvani et al., 2003, Waki et al., 2003). These multimers are comprised of the low (LMW) 
and high-molecular weight (HMW) isoforms (Kadowaki et al., 2006), with the latter 
proposed to be the most bioactive (Waki et al., 2003). The metabolic relevance of adiponectin 
resides in its multiple described functions as an insulin-sensitizer, as well as its anti-
inflammatory and antioxidant activities (Kadowaki et al., 2006). Most of the studies 
addressing this protein have focused on adipose-tissue secreted adiponectin which can be 
found in the circulation (Kadowaki et al., 2006). However, adiponectin is also produced by 
muscle cells and it can act in an autocrine/paracrine manner through the stimulation of two 
adiponectin receptors (AdipoR), -1 (mostly present in skeletal muscle), and -2 (mostly 
prevalent in liver) (Jortay et al., 2012, Jortay et al., 2010, Krause et al., 2008). Delaigle et al. 
were one of the first to report the presence of adiponectin mRNA and protein in mouse 
tibialis anterior muscles. Interestingly, they reported that inflammatory challenges such as 
I.P. injections of LPS were able to induce increases in adiponectin mRNA (8-fold) and total 
muscle adiponectin protein (~2-fold), findings that were confirmed by cultivating C2C12 
myotubes with interferon ɣ plus TNF, where similar increases in adiponectin mRNA (20-
fold) were seen (Delaigle et al., 2004); this suggests that muscle adiponectin induction might 
act as a protective measure against metabolic challenges. Moreover, the same research group 
tested this hypothesis further by comparing the metabolic consequences of I.P. injections of 
LPS in tibialis anterior muscles from wild-type C57BL6 male mice and adiponectin KO 
mice. As expected, LPS reproduced the increases in total muscle adiponectin protein in 
wildtype animals, along with increases in the protein content of oxidative stress (4-hydroxy-
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2-nonenal (HNE), heme oxygenase 1 (HO-1), and peroxiredoxin -3 and -5), inflammation 
(TNF), and apoptosis (caspase-6) markers. Intriguingly, muscles from KO animals exhibited 
further increases in those stress markers, giving more support to the idea that induction of 
muscle adiponectin acts in a local tissue skeletal protective mechanism. Moreover, 
electrotransfer through electroporation of the adiponectin gene to tibialis anterior of KO 
animals reversed these changes (Jortay et al., 2010).  
 
However, it seems that adiponectin induction in skeletal muscles in not homogenous through 
the tissue, given it has been described that fibres with higher intramyocellular lipid content 
are the ones where the higher levels of adiponectin can be found (e.g. type IIA and type 
IIB/X fibres) (Krause et al., 2008). This suggests that adiponectin expression in skeletal 
muscles might be tightly related to oxidative pathways to produce energy. Iwabu et al. 
investigated the pathways by which adiponectin induces its metabolic effects in skeletal 
muscle by analysing the muscle phenotype of muscle-specific AdipoR1 KO mice. Mutant 
mice were glucose intolerant, insulin resistant, and showed lower endurance capacities. Their 
muscles exhibit a lower number of type I fibres (mostly oxidative) and lower levels of β-
oxidation, changes that confirmed that adiponectin action on skeletal muscles influence its 
oxidative capacity. Furthermore, lower levels of mRNA (0.6-fold) and protein (0.6-fold) of 
PGC-1ɑ were found in mutant animals compared with its wildtype peers, along with 
disturbances in the deacetylase activity of Sirtuin 1 (SIRT1), which also further facilitates 
PGC-1ɑ activation (Iwabu et al., 2010). Altogether, these findings highlight the metabolic 
relevance of adiponectin signalling in skeletal muscle, which seems to be mostly related to its 
protective influences on oxidative pathways and mitochondrial function.  
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1.2.9 Muscle adiponectin induction during obesity 
The effect of muscle adiponectin on metabolism in animal models of obesity has been studied 
mainly in the systemic, endocrine effects. The use of dietary interventions (Bonnard et al., 
2008, Farias et al., 2012, Jortay et al., 2012, Liu et al., 2009, Pierard et al., 2016, Safwat et 
al., 2013, Vu et al., 2013, Yang et al., 2006) and transgenic animals (Delaigle et al., 2006, Liu 
et al., 2009) (e.g. ob/ob and db/db mice) have been helpful in this field. For instance, after 20 
weeks of high fat/high sucrose diet, rat gastrocnemius muscles exhibit decreases in total 
adiponectin (~0.5-fold), changes that were rescued by a peroxisome proliferator-activated 
receptor ɣ (PPARɣ) agonist (Yang et al., 2006). These results are in concordance with studies 
that showed muscle-specific overexpression of PPARɣ in mice induced muscle adiponectin 
production (Amin et al., 2010). Others have also reported decreases in muscle adiponectin 
protein in the soleus muscles (0.6-fold) of db/db mice (Liu et al., 2009). Interestingly, 
contrary findings have been described in mice after 8 (Jortay et al., 2012) and 16 weeks of 
high fat/high sucrose consumption (Bonnard et al., 2008) and also in ob/ob mice (Delaigle et 
al., 2006) where increases of adiponectin (~1.6-fold) have been reported. These discrepancies 
could be due to the model used to study these responses, the muscles analysed, along with 
which adiponectin isoforms were measured, as results from all the previously mentioned 
studies measured total adiponectin content (all isoforms altogether) or a single isoform of 
adiponectin (30kDa). Lack of measurement of the most bioactive isoforms of adiponectin 
might be considered as a limitation, given the physiological ability of adiponectin to form 
multimers. In support of this, Liu et al. in two different experiments highlighted the relevance 
of measuring different muscle adiponectin isoforms, along with the comparison between 
different muscles. First, in Wistar rats they investigated the effect of 9 weeks of high fat/high 
sucrose diet on gastrocnemius adiponectin induction. Decreases in adiponectin mRNA were 
found (0.6-fold), despite no changes in total protein content. Interestingly, only the high-
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molecular weight (HMW) isoform was reduced (~0.7-fold). Moreover, in a separate 
experiment in db/db mice they compared muscle adiponectin profiles of soleus and extensor 
digitorum longus (EDL) muscles, by measuring total muscle adiponectin plus three different 
isoforms, HMW, medium molecular weight (MMW), and low-molecular weight (LMW). 
Intriguingly, the highly oxidative soleus showed decreases in total (0.8-fold) and HMW 
adiponectin (~0.6-fold) and increases in lower isoforms such as MMW (~1.3-fold), whereas 
the highly glycolytic EDL exhibited increases only in the LMW (~2-fold) and the other 
isoforms were unchanged compared to their wildtype peers (Liu et al., 2009). These findings 
suggest that in order to reach proper conclusions regarding muscle adiponectin induction, the 
type of muscle analysed, along with analysis of various adiponectin isoforms, are essential 
requirements to facilitate rational interpretation of studies in this field. 
 
Fewer studies have focused on the analysis of the mediators of adiponectin signalling in 
skeletal muscle during obesity. These studies have mostly focused on the effects of HFD on 
the expression of skeletal muscle adiponectin receptors and one of its immediate downstream 
factors such as adaptor protein, phosphotyrosine interacting with PH domain and leucine 
zipper 1 and 2 (APPL1-2) (Farias et al., 2012, Pierard et al., 2016, Vu et al., 2013), which has 
been associated with the regulation of the insulin receptor signalling pathway, particularly 
under adiponectin signalling (Liu and Sweeney, 2014). In swiss mice after 12 weeks of HFD, 
Farias et al found lower levels of AdipoR1 protein (~0.3-fold) in their skeletal muscles. 
Unfortunately, the specific muscle used for analysis was not described and muscle-specific 
adiponectin measurements were not conducted. Nevertheless, decreases in APPL1 protein 
(~0.25-fold) were also found in those animals (Farias et al., 2012), suggesting that HFD also 
promotes dysregulations on muscle adiponectin downstream factors as well. However, there 
are discordant findings between different studies, given that no changes in muscle AdipoR1 
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and AdipoR2 protein were found in C57BL6 mice after 10 weeks of HFD. Notably, no 
changes in APPL1 or APPL2 were seen, however the specific muscle analysed was also not 
reported (Vu et al., 2013), which hinders further interpretation. Moreover, differential 
responses between AdipoRs have been described after 10 weeks of HFD in C57BL6 mice, 
where gastrocnemius muscle showed higher protein levels of AdipoR2 (1.3-fold), whereas no 
changes were seen in AdipoR1 (Pierard et al., 2016). Given that there is no certainty that the 
muscle groups analysed were the same in these studies, future research should aim to 
elucidate if the differential response described here was because of an eventual differential 
response to metabolic stress, particularly HFD, between different muscles. This is plausible 
given the previously described specificity of metabolic actions regarding muscle adiponectin 
induction and its downstream factors. Table 1 provides a summary of previous studies 
examining the effects of obesity on the induction of muscle adiponectin.  
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Table 1. Effects of obesity on skeletal muscle adiponectin induction. 
Study Design Muscle Species 
Results 
Adiponectin 
 
AdipoRs Downstream 
factors 
Yang et al. 
2006(Yang et al., 
2006) 
Sprague-Dawley rats.  
20 weeks of high fat/high 
sucrose diet. 
Gastrocnemius Protein ↓ (total) -- -- 
mRNA -- -- -- 
Delaigle et al. 
2006(Delaigle et al., 
2006) 
ob/ob mice. Tibialis anterior Protein ↑ (total) -- -- 
mRNA ↑  -- -- 
Bonnard et al. 
2008(Bonnard et al., 
2008) 
C57BL6 mice.  
4 weeks of high fat/high 
sucrose diet. 
Gastrocnemius Protein ↔ (single 
form) 
 
-- -- 
mRNA -- -- -- 
C57BL6 mice. 
16 weeks of high fat/high 
sucrose diet. 
Gastrocnemius Protein ↑ (single form) -- -- 
mRNA -- -- -- 
Liu et al. 2009(Liu 
et al., 2009) 
Wistar rats. 
9 weeks of high fat/high 
sucrose diet. 
 
Gastrocnemius Protein ↔ (total) 
↓ (HMW) 
-- -- 
mRNA ↓ -- -- 
db/db mice. EDL 
Soleus 
Protein ↓ (total; 
soleus) 
↓ (HMW; 
soleus) 
↑ (MMW; 
soleus) 
-- -- 
48 
 
↔ (LMW; 
soleus) 
↔ (total; 
EDL) 
↔ (HMW; 
EDL) 
↔ (MMW; 
EDL) 
↑ (LMW; 
EDL) 
mRNA -- -- -- 
Farias et al. 
2012(Farias et al., 
2012) 
Swiss mice. 
12 weeks of HFD (60% fat) 
Not declared Protein -- ↓ -1 ↓ APPL1 
mRNA -- -- -- 
Jortay et al. 
2012(Jortay et al., 
2012) 
C57BL6 mice. 
8 weeks of high fat/high 
sucrose diet 
Tibialis anterior Protein ↑ (total) -- -- 
mRNA -- -- -- 
Safwat et al. 
2013(Safwat et al., 
2013) 
Albino rats. 
12 weeks of HFD (42% fat) + 1 
I.P. injection of STZ. 
Gastrocnemius Protein -- -- -- 
mRNA ↓ -- -- 
Vu et al. 2013(Vu et 
al., 2013) 
C57BL6 mice. 
10 weeks of HFD (60% fat). 
Not declared Protein -- ↔ -1 
↔ -2 
↔ APPL1 
↔ APPL2 
mRNA -- -- -- 
Pierard et al. 
2016(Pierard et al., 
2016) 
C57BL6 mice. 
10 weeks of HFD (60% fat) 
Gastrocnemius Protein -- ↔ -1 
↑ -2 
-- 
mRNA -- -- -- 
 
Abbreviations: AdipoRs, adiponectin receptors; mRNA: messenger RNA; EDL: extensor digitorum longus; HMW: high-molecular weight; 
MMW: medium-molecular weight; LMW: low-molecular weight; HFD: high-fat diet; APPL: adaptor protein, phosphotyrosine interacting with 
PH domain and leucine zipper 1; I.P.: intraperitoneal; STZ: streptozotocin.  
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1.2.10 Effects of exercise on muscle adiponectin induction 
In terms of therapeutic strategies that could induce muscle adiponectin, physical exercise has 
been increasingly tested in different modalities and animal models with promising results. In 
lean animals, exercise has exhibited a positive influence on muscle adiponectin, given that 
after 6 months of treadmill training, gastrocnemius of Sprague-Dawley rats showed increases 
of mRNA (~6-fold) and in the single isoform of adiponectin (30 kDa; ~1.3-fold). 
Interestingly, these changes were associated with increases in AdipoR1 (~2-fold) protein 
levels (Dai et al., 2013), suggesting a global impact of exercise on muscle adiponectin 
induction and in its mediators. Moreover, using a different experimental approach, Goto et al. 
investigated the effects of different levels of mechanical loads on muscle adiponectin 
induction. First, they overloaded soleus muscles in C57BL6 mice by excision of agonists 
(plantaris and gastrocnemius), finding that after 3 weeks in this condition, increases in the 
single form of adiponectin were found in soleus muscles (~1.5-fold), changes that were 
associated with increases in APPL1 protein (~3-fold). In a different experiment, Goto et al 
investigated the effect of decreases in mechanical load on soleus muscle through hindlimb 
suspension for 2 weeks in C57BL6 mice with a subsequent recovery period of 2 and 4 weeks. 
Decreases of AdipoR1 mRNA levels were seen after 2 weeks of suspension (~0.8-fold), 
whereas in the recovery process increases in the single form of adiponectin (~1.3-fold) and 
APPL1 protein levels (~1.7-fold) were described after 2 weeks of recovery (Goto et al., 
2013). These findings highlight the relevance of muscle adiponectin and its signalling when 
skeletal muscles are challenged by different levels of mechanical load. Nevertheless, not all 
the studies in this topic reported this trend of changes, given that soleus muscles from Wistar 
rats did not exhibit changes in total muscle adiponectin protein after 12 weeks of treadmill 
training at low, moderate, and high intensities (Garekani et al., 2011). These differences 
could be explained by the difference between the outcomes measured, where the increases of 
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muscle adiponectin were reported when its single form was measured, suggesting that 
different adiponectin isoforms should be measured in order to achieve interpretable 
conclusions.  
 
The effects of exercise on muscle adiponectin induction in animal models of obesity have 
also been explored. In this context, gastrocnemius muscles from diabetic (streptozotocin-
induced) albino rats fed with HFD for 12 weeks, exhibited increases of adiponectin mRNA 
levels (~3-fold) following 9 weeks of swimming training in comparison with untrained peers, 
however no protein data was given (Safwat et al., 2013). Furthermore, increased protein 
levels of AdipoR1 (~2-fold) and APPL1 (~2.5-fold) were seen in skeletal muscles (specific 
muscle not indicated) from Swiss mice that were fed with HFD and simultaneously 
undergoing swimming training for 12 weeks, compared to its untrained counterparts (Farias 
et al., 2012). Notably, these results differ from what Pierard et al. reported in gastrocnemius 
muscles from C57BL6 mice where, after 10 weeks of HFD and simultaneous treadmill 
training at moderate intensity for 8 weeks, AdipoR1 protein levels were unchanged (Pierard 
et al., 2016). These discrepancies raise questions regarding the relevance of the muscle group 
analysed, along with the eventual importance that the type of exercise could have on muscle 
adiponectin induction, particularly in a model of metabolic dysfunction, such as obesity. 
Therefore, future research in this topic should compare different exercise protocols on muscle 
adiponectin induction in animal models of obesity, along with the comparison of this 
response between different muscle groups with differential metabolic and mechanical 
functions. A summary of the studies regarding the effects of exercise and different levels of 
mechanical loads on muscle adiponectin induction is displayed in Table 2.  
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Table 2. Effects of exercise and increase of mechanical load on skeletal muscle adiponectin induction. 
Study Animal | Diet | Intervention Muscle Results Adiponectin (AdipoRs) Downstream 
factors 
Garekani et al. 
2011(Garekani et al., 
2011) 
Wistar rats | Chow standard 
diet | Treadmill training (0% 
slope, 60 min/day, 5 
days/week, for 12 weeks) at 
three different intensities: 
Low: 20 m/min 
Moderate: 28 m/min 
High: 34 m/min 
Soleus Protein ↔ (total; in all 
intensities) 
-- -- 
mRNA -- -- -- 
Farias et al. 
2012(Farias et al., 
2012) 
Swiss mice | 12 weeks of HFD 
(60% fat) | Swimming training 
(2x30 min/day, 5 days/week, 
for 12 weeks) 
Not provided Protein -- ↑ -1 (vs HFD 
untrained) 
↑ APPL1 (vs 
HFD 
untrained) 
mRNA -- -- -- 
Dai et al. 2013(Dai et 
al., 2013) 
Sprague-Dawley rats | Chow 
standard diet | Treadmill 
training (15% slope, 20 
m/min, 60 min/day, 5 
days/week, 6 months) 
Gastrocnemius Protein ↑ (single 
form) 
↑ -1 -- 
mRNA ↑ -- -- 
Safwat et al. 
2013(Safwat et al., 
2013) 
Albino rats | 12 weeks of HFD 
(42% fat) + 1 I.P. injection of 
STZ | Swimming training (10-
40 min x 1-4 sessions/day, 5 
days/week, for 9 weeks) 
Gastrocnemius Protein -- -- -- 
mRNA ↑ (vs HFD 
untrained) 
-- -- 
Goto et al. 2013(Goto 
et al., 2013) 
C57BL6 mice | Chow standard 
diet | Overloading of soleus 
muscle by excision of agonists 
Soleus Protein ↑ (single form; 
after 3 weeks) 
-- ↑ APPL1 
(after 3 
weeks) 
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for 1 and 3 weeks. mRNA ↑ (after 1 and 
3 weeks) 
↔ -1 
↑ -2 (after 1 
and 3 weeks) 
 
C57BL6 mice | Chow standard 
diet | Hindlimb suspension for 
2 weeks and recovery for 2 
and 4 weeks. 
Soleus Protein ↑ (single form; 
after 2 weeks 
of recovery) 
-- ↑ APPL1 
(after 2 weeks 
of recovery) 
mRNA ↔ ↓ -1 (after 2 
weeks of 
hindlimb 
suspension) 
↔ -2 
-- 
Pierard et al. 
2016(Pierard et al., 
2016) 
C57BL6 mice | 10 weeks of 
HFD (60% fat) | Treadmill 
training (70% of MRC, 60 
min/day, 5 days/week, for 8 
weeks) 
Gastrocnemius Protein -- ↑ -1 (vs 
Chow 
untrained) 
↔ -1 (vs 
HFD 
untrained) 
↔ -2 (vs 
Chow 
untrained) 
↔ -2 (vs 
HFD 
untrained) 
-- 
mRNA -- -- -- 
 
Abbreviations: AdipoRs, adiponectin receptors; mRNA: messenger RNA; HFD: high-fat diet; APPL: adaptor protein, phosphotyrosine 
interacting with PH domain and leucine zipper 1; I.P.: intraperitoneal; STZ: streptozotocin.  
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1.2.11 Skeletal muscle extracellular matrix and effects of exercise and obesity 
For a detailed description of this topic, please see the review article to follow, entitled: 
The emerging role of skeletal muscle extracellular matrix remodeling in obesity and 
exercise (Martinez-Huenchullan et al., 2017a) 
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Supplementary Table 1. Summary of the search strategy for the ‘Obesity Reviews’ article., 
entitled ‘The emerging role of skeletal muscle extracellular matrix remodeling in obesity 
and exercise (Martinez-Huenchullan et al., 2017a)’. 
 
Search Search Terms 
Initial number of 
studies 
Final number of 
studies included 
Aim 1:  To examine skeletal muscle ECM remodeling in the context of obesity 
1 Muscle + extracellular matrix + obesity 41 3 
2 
Muscle + extracellular matrix + high 
fat diet 
24 2 
3 
Muscle + extracellular matrix + insulin 
resistance 
41 8 
4 Muscle + collagen + obesity 69 2 
5 Muscle + collagen + high fat diet 92 2 
6 Muscle + collagen + insulin resistance 52 5 
Aim 2:  To examine the effects of exercise on skeletal muscle ECM during obesity 
7 Search 1 to 6 + overload 19 0 
8 Search 1 to 6 + exercise 45 4 
9 Search 1 to 6 + training 55 5 
10 Search 1 to 6 + physical activity 34 5 
Aim 3: To examine the effects of exercise on skeletal muscle ECM 
11 
Muscle + extracellular matrix + 
overload 
56 2 
12 
Muscle + extracellular matrix + 
exercise 
122 12 
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13 
Muscle + extracellular matrix + 
training 
46 6 
14 
Muscle + extracellular matrix + 
physical activity 
9 1 
15 Muscle + collagen + overload 81 0 
16 Muscle + collagen + exercise 212 14 
17 Muscle + collagen + training 137 6 
18 Muscle + collagen + physical activity 42 0 
RAW TOTAL 1177 77 
Duplicates between searches 46 
TOTAL 31 
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1.2.12 Summary comments based on this literature review. 
This literature review has highlighted that obesity and type 2 diabetes cause functional and 
structural changes in skeletal muscle. These changes include induction of skeletal muscle 
extracellular matrix and myokines such as adiponectin, the latter which may have endocrine 
as well as paracrine and autocrine effects in a muscle, fibre type and myocyte specific 
manner. Intervention with various forms of exercise regimen can have beneficial effects 
systemically and in skeletal muscle.  However, there are few studies that have reported 
effects of differing isocaloric exercise regimens in skeletal muscle structure and function in 
the presence of diet-induced obesity, nor have the mechanism(s) of such differential effect 
been defined. 
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Chapter 2 
Materials and Methods  
 
2.1 Animal Ethics Approval 
 
The studies performed during this project were approved by the University of Sydney Animal 
Ethics Committee (Protocol #2015/816; chapters 3, 4, and 5; Appendix 1) and the Royal 
Prince Alfred Research Ethics and Governance Office (Protocol #2015/024; chapter 6; 
Appendix 2). The experiments described herein were carried out according to the guidelines 
laid down by the New South Wales Animal Research Act and the 8th Edition of the 
Australian code for the care and use of animals for scientific purposes. 
 
2.2 Overview of studies outcomes and measurements 
 
In the following table, a brief description of the different studies performed in this thesis are 
presented, along with the different techniques used in each of them. 
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Table 3. Summary of the studies and techniques involved in this thesis. 
Study 
Study 
type 
Animal 
Phenotyping 
Tissue-specific measurements 
mRNA Protein 
Tissue 
structure 
Muscle 
function 
tests 
rt-
qPCR 
WB IHC 
H-
E 
PSR 
Preventive 
effects of 
exercise 
(Chapters 3-4) 
L 
✓ ✓ ✓ ✓ ✓  ✓ 
Treatment 
effects of 
exercise 
(Chapter 5) 
L 
✓ ✓ ✓ ✓ ✓  ✓ 
Effects of 
metabolic stress 
on muscle 
structure 
(Chapter 6) 
C-S 
✓ ✓ ✓ ✓  ✓ ✓ 
 
Abbreviations: mRNA: messenger RNA; rt-qPCR: real time quantitative PCR; WB: western 
immunoblot; IHC: immunohistochemistry; H-E: haematoxylin and eosin stain; PSR: 
picrosirius red stain, L: longitudinal, C-S: cross-sectional. 
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2.3 Animals, diet, and diabetes induction 
 
C57BL/6 mice were utilised to perform the studies described in this thesis due to the previous 
experimental experience of our group and the global acceptance of this strain for the study of 
metabolic disturbances (Nilsson et al., 2012). For the studies that included exercise, animals 
of 8-9 weeks of age were used, as at that age muscle development is expected to be near-
complete (White et al., 2010). For the cross-sectional study, animals at 4-5 weeks of age were 
employed and the length of the intervention was planned to be for 30 weeks. 
 
As normal diet, laboratory standard chow was used in all studies, the source of which differed 
depending on the animal house where the study was conducted. The exercise studies were 
performed in the Charles Perkins Centre Animal House, which used Meat free mouse diet, 
from Specialty feeds ®, WA, Australia. The cross-sectional study was performed at the Royal 
Prince Alfred Animal House, where they use Premium rat & mouse pellets, from Gordon’s 
®, NSW, Australia. Both diets have similar compositions with 12% of energy coming from 
fat. In the case of the high-fat diet (45% of its calories from fat), this was prepared in-house 
as described in previously published studies from our group (Lo et al., 2011). The ingredients 
incorporated to the high-fat diet are described in Table 4. 
 
  
75 
 
 
Table 4. High-fat diet composition. 
 
Ingredient Weight 
(gram) 
% 
weight 
kCal %kCal 
Casein  261.0 22.82 955.55 17.26 
Sucrose  224.0 19.59 910.13 16.63 
Starch  214.8 18.78 759.80 13.88 
Mineral mix  51.0 4.46 0.00 0.00 
Bran  57.0 4.98 230.16 4.21 
Methionine  3.4 0.30 0.00 0.00 
Gelatine  23.0 2.01 79.83 1.46 
Choline bitartrate  4.6 0.40 0.00 0.00 
Vitamin mix  14.8 1.29 0.00 0.00 
Sunflower oil  34.0 2.97 284.42 5.2 
Lard  250.0 21.86 2210.80 40.40 
Cholesterol  6.0 0.52 53.09 0.97 
Total  1174.2 100.00 5483.78 100.00 
 
 
Diabetes induction was performed using low dose intraperitoneal injections of streptozotocin 
(STZ; 65 mg/kg) over three consecutive days (Lo et al., 2011). Ongoing diabetes presence 
was confirmed by random measurements of blood glucose in the animals after the injections, 
where the threshold was set at 11-12 mmol/L. With this regimen no mice required insulin 
therapy and blood glucose levels (BGLS) were typically in the 11-20 mM range, random. 
 
2.4 Study designs 
 
2.4.1 Exercise studies 
 
Two separate studies were conducted to test the preventive and treatment effects of exercise 
during obesity. The preventive model was designed to mimic the clinical scenario of healthy 
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individuals that start consuming an unhealthy diet (e.g. high-fat diet) and exercising 
simultaneously, and the treatment model was designed to investigate the effects of exercise in 
already obese individuals. 
2.4.1.1 Preventive approach 
Seventy-Two C57BL/6 10-week old male mice were used in this study (Animal Resources 
Centre, Perth, Australia). Mice were randomly divided into two dietary groups (n=36/group) 
and fed either a high-fat diet (45% fat), or standard laboratory chow (12% fat) (Specialty 
Feeds ®, WA, Australia), ad libitum, for 10 weeks. Mice in each dietary group were then 
randomised to one of three groups: no exercise control group (untrained), constant moderate-
intensity endurance (END) or high-intensity interval training (HIIT). Consequently, six 
groups (n=12/group) were analysed during this study: CHOW untrained, CHOW+END, 
CHOW+HIIT; and HFD untrained, HFD+END, HFD+HIIT. Dietary and exercise 
interventions were delivered simultaneously for 10 weeks and phenotyping studies were 
performed before and after the intervention. Sample size for this study (and also for the 
studies described in 2.4.1.2 and 2.4.2) was calculated as follows: setting a statistical 
significance of <0.05; power of 0.8 and assuming a variance of 25% in the outcomes of 
interest, the minimum number of mice per group should be 8 to 10. We added extra animals 
to account for lack of exercising in some mice (reportedly about 10-20%). For euthanasia, 
animals were placed in a sealed box (Stinger ®, Advanced Anaesthesia Specialist, Sydney, 
Australia) and isoflurane (3%) in oxygen was delivered to induce a deep anaesthetic state. 
Animals were then euthanized by exsanguination through cardiac puncture. Blood, 
quadriceps, gastrocnemius, and masseter muscles, subcutaneous and epidydimal fat depots, 
were collected and stored at -80 °C for later analysis. This is summarized in Figure 1. 
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Figure 1. Preventive approach study design. One week prior to the beginning of the study, all 
animals were acclimated to the treadmill. Dietary intervention (CHOW standard and high-fat 
diet (HFD) started simultaneously with the two isocaloric exercise programs (constant-
moderate endurance (END) and high-intensity interval training (HIIT)). Exercise sessions 
were delivered three times per week, with a duration of 40 min each, for 10 weeks. During 
the week following the last training session, post-treatment measurements were conducted. 
Samples were collected at least 72 hr after the last physical effort to rule out any carry over 
effect. 
 
2.4.1.2 Treatment approach 
Seventy-two 8 to 9-week old male C57BL/6 mice were used in this study (Animal Resources 
Centre, Perth, Australia). Mice were randomly allocated to two dietary groups (n=36/group) 
and fed either a high-fat diet (HFD; 45% kcal fat) which was prepared in-house as indicated 
in Table 4, or standard laboratory chow (12% kcal fat) (Specialty Feeds ®, WA, Australia), 
ad libitum for 10 weeks. 
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After that time, dietary group were randomized to either no exercise, constant moderate-
intensity endurance (END) or high-intensity interval training (HIIT). Untrained animals 
(n=12/diet) not exposed to additional exercise beyond the acclimation period were used as 
controls for exercise. Consequently, six groups (n=12/group) were analysed for this study: 
CHOW no exercise (untrained), CHOW+END, CHOW+HIIT; and HFD untrained, 
HFD+END, HFD+HIIT. Dietary conditions and exercise interventions were continued 
simultaneously from weeks 11 to 20, and phenotyping studies were performed at the end of 
the exercise intervention. Animals were euthanized as described above blood, quadriceps 
muscle, subcutaneous adipose tissue, and liver were collected for later analysis. The 
treatment protocol is summarized in Figure 2. 
 
 
 
Figure 2. Treatment approach study design. One week prior to the beginning of the study, all 
animals were acclimated to the animal house. Animals were divided into two groups 
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(n=36/group) and commenced on either standard laboratory diet (CHOW) or high-fat diet 
(HFD). After 10 weeks, when the mice fed the HFD had developed an obese phenotype, 24 
animals from each group were acclimated to the treadmill prior to beginning one of the two 
isocaloric exercise programs (constant-moderate endurance (END) and high-intensity interval 
training (HIIT)). Untrained animals (n=12/diet) not exposed to additional exercise beyond the 
acclimation period were used as controls for exercise. Exercise sessions were delivered three 
times per week, with a duration of 40 min each, for 10 weeks. During the week following the 
last training session, post-treatment measurements were conducted. Samples were collected at 
least 72 hr after the last physical effort to rule out any carry over effect. 
 
2.4.1.3 Exercise Prescription 
After 1 week of treadmill acclimation (6 m/min for 10 min), a maximal running capacity 
(MRC) test was performed. This progressive test started from a speed of 6 m/min and 
increased by 3 m/min every three min until exhaustion. Exhaustion was defined as the 
inability of the animal to reach the end of the exercise lane after encouragement with 5 
mechanical stimuli (soft brush) delivered within one minute. The final speed was defined as 
the MRC (100%) and the distance covered was recorded as the aerobic performance of the 
animal. The exercise intensity of the two different training programs was matched using the 
initial MRC. The exercise programs were designed to be theoretically isocaloric (same 
distance covered per session, same number of session, same average intensity, and same time 
per session), which was achieved as follows: END constituted a running session at 70% of 
the MRC for 40 min, while HIIT was delivered in eight bouts (2.5 min each) at 90% of the 
MRC alternating activity with eight rest periods (2.5 min each) at 50% of the MRC (Figure 
3). For both the prevention and treatment studies exercise training was commenced after the 
initial 1 week of treadmill acclimation. The END or HIIT programs were performed in the 
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morning, three times per week, for 10 weeks. Untrained animals were not exposed to 
additional exercise beyond the acclimation period. 
 
 
Figure 3. Prescription for one exercise session. The high-intensity interval training (HIIT) 
session is represented in grey, whereas the red line represents the constant-moderate intensity 
(END) session. The training programs were isocaloric with each other. 
 
2.4.2 Cross-sectional study to examine the impact of HFD and/or diabetes on muscle 
function 
 
Fifty-one 5-week old male C57BL/6 mice were utilised in this study (Animal Resources 
Centre, Perth, Australia). After one week of housing acclimation, mice were randomly 
allocated to two dietary groups and fed either a high-fat diet (HFD; 45% kcal from fat; n=25) 
prepared in-house as per Lo et al. (Lo et al., 2011), or standard laboratory chow (CHOW; 
12% kcal from fat; n=26) (Gordon’s ®, NSW, Australia), ad libitum for 30 weeks. After the 
first 15 weeks of feeding, a sub-group of each dietary condition were rendered diabetic using 
intraperitoneal injections of low-dose STZ (three consecutive days, 65 mg/kg each day), 
namely DM (n=14) and HFD+DM (n=14). Animals were euthanized under isoflurane 
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anaesthesia by exsanguination through cardiac puncture. Blood and quadriceps muscle were 
then collected for later analysis. This is summarized in Figure 4. 
 
 
 
Figure 4. Cross-sectional study design. Animals were maintained in either standard diet or 
high fat (HFD) for 15 weeks prior to diabetes induction in a sub set of animals of each dietary 
group. Diabetes was induced with intraperitoneal injections of low-dose streptozotocin (65 
mg/kg) for three consecutive days. Diabetes was confirmed three days later by measurement 
of random blood glucose level (blood glucose ≥ 11-12 mmol/L), animals were then 
maintained in their respective diet groups for a further 15 weeks. Quadriceps muscle and 
blood for plasma was collected at euthanasia. 
 
2.5 Animal Phenotyping 
 
2.5.1 Insulin tolerance test 
To assess insulin sensitivity, insulin tolerance tests were performed as follows. Animals were 
fasted for 4 hours of fasting, small nick was placed in the tail with a scalpel and blood (~2 µl) 
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was obtained for measurement of blood glucose using a FreeStyle Lite glucometer (Abbott 
Diabetes Care, Alameda, CA, USA). This measurement was considered as the baseline value. 
Subsequently, insulin (0.75 IU/kg of body weight) was injected intraperitoneally and blood 
was obtained as described above at 5, 15, 30 and 60 min after insulin injection. Blood glucose 
excursion was calculated as Area Under the Curve (AUC) where a lesser reduction of blood 
glucose, thus a higher AUC, was indicative of higher insulin resistance (Lo et al., 2011). 
 
2.5.2 Muscle function testing 
For a detailed description of muscle function tests, along with an exploration of their utility 
and reliability in high-fat diet fed mice, please see the methods original article entitled: 
Utility and reliability of non-invasive muscle function tests in high-fat-fed mice 
(Martinez-Huenchullan et al., 2017b), at the end of this chapter. 
 
As main conclusions from this study, grip strength exhibited the highest intra-rater reliability 
in CHOW and high-fat diet fed animals at each of the time-points (5, 10, and 20 weeks of 
dietary intervention), whereas the four-limb hanging test was not reliable enough to be used 
in HFD animals. Moreover, the hang wire test was sensitive enough to detect muscle 
dysfunction at early stages of high-fat diet intake. Therefore, in this thesis, grip strength and 
hang wire tests were selected to quantify muscle function in the experimental animals. 
 
2.5.3 Body composition measurements (EchoMRI) 
Echo MRI (EchoMRI TM, Houston, USA) was used to assess animal body composition. 
Measurements of total body fat, lean mass, and water content were obtained by placing 
animals in a ventilated plastic tube with gentle restriction to prevent movements of the animal 
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during the MRI measurement. The animal secured in the tube, was then placed in the 
instrument and the measurements were obtained over a period of ~90 seconds. The assistance 
of Dr. Nana Sunn (Charles Perkins Centre – University of Sydney) during this procedure is 
acknowledged. 
 
2.5.4 Spontaneous physical activity measurements (Metabolic cage) 
Spontaneous physical activity (arbitrary units) was measured using the Promethion® 
Metabolic Cage (Sable Systems International, North Las Vegas, NV, USA). Mice were 
individually placed in the cage for ~48 h period with ad libitum access to water and food. 
Displacement and voluntary running wheel usage were counted and combined to obtain the 
total spontaneous physical activity. Data was collected for 36 h after a 4 h period of 
acclimatization. ExpeData analysis software was used to extract the raw data. This 
information was then transferred to an excel spreadsheet where it was cleaned for the final 
analysis. The assistance of Dr. Kim Bell-Anderson (Charles Perkins Centre – University of 
Sydney) in undertaking this procedure is gratefully acknowledged. 
 
2.5.5 Plasma Insulin 
Plasma insulin was assessed using a commercial kit (Merck®, EZRMI-13K) according to the 
manufacturer’s instructions. Briefly, a standard curve was prepared using known 
concentrations of an insulin standard (from 10 to 0.2 ng/mL). Analysis was performed by 
addition of plasma (10 μl) and detection antibody (Biotinylated anti-insulin antibody; 80 µl). 
The plate was then covered and incubated at room temperature on an orbital microtiter plate 
shaker (400 to 500 rpm). After 2 hours the plate sealer was removed, and solutions were 
decanted from the plate on absorbent paper. The wells were then washed 3 times with diluted 
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Wash Buffer (300 µl) prior to addition of enzyme solution (Streptavidin-horseradish 
peroxidase conjugate, 100 µl), the plate was then covered and left for incubation at room 
temperature on a plate shaker for 30 mins. The solutions were then decanted, and each well 
was then washed 6 times with Wash Buffer (300 µl). The substrate Solution (100 µl) was 
added and the plates were again sealed and incubated at room temperature shaking for 15 
mins to develop the blue coloration. The reaction was stopped by addition of stop solution 
(100 µl) and the colour was read on a spectrophotometer (Tecan ®, Infinite M1000 
PROTecan) at 450 nm and 590 nm. The absorbance units in each well were recorded and 
plasma insulin concentration was determined from the standard curve. 
 
2.5.6 Plasma triglycerides 
Triglycerides (TAG) in plasma were quantified using a commercial kit (Sigma®, catalog 
number: TR0100) following the manufacturer instructions. Briefly, a working solution for 
each sample was prepared consisting of 4 parts of glycerol reagent (200 μl) and 1 part of 
TAG reagent (50 μl). Then, 250 μl of working solution followed by 2.5 μl of plasma were 
added to each well of a 96-well plate. The plate was then incubated at room temperature for 
15 min with gentle shaking. A positive or standard (sample with known glycerol 
concentration = 2.5 mg/mL) and negative (water) control were included on each plate. The 
colour developed was read with a spectrophotometer (Tecan) at 540 nm, and the TAG (in 
mg/mL) was calculated as follows: 
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2.5.7 Muscle triglycerides 
To quantify muscle TAG content, lipids were extracted from ~10 mg of muscle. The sample 
was mixed in 500 μl of extraction buffer (chloroform-methanol (2:1) during the 
homogenization on a bead beater (3 pulses x 1 minute each). After two hours of incubation 
and occasional shaking at room temperature, 500 μl of 0.9% (w/v) NaCl was added and the 
tubes were vortexed. The samples were then centrifuged at 2800 rpm for 3 min at room 
temperature. Afterwards, 200 μl of infranatant were extracted and transferred to a glass tube. 
The contents of the tubes were dried using a nitrogen-based sample concentrator. The 
resulting pellet was then dissolved in 10 μl of 100% EtOH, and 300μl of TAG reagent (Roche 
®, catalog number 11876023). After 15 min of incubation at room temperature, 250 μl of 
sample was aliquoted to wells of a 96-well plate and the absorbance was read with a 
spectrophotometer (Tecan) at 492 nm and muscle TAG content was calculated from a 
standard curve developed from known concentrations of glycerol (from 5 to 0.08 mg/mL) and 
expressed as mg/mL per mg of tissue. 
 
2.5.8 Liver function tests 
Alkaline phosphatase (ALP), alanine transaminase (ALT) and aspartate transaminase (AST) 
were measured by NSW Health Pathology, Clinical Chemistry at Royal Prince Alfred 
Hospital on a Roche® Cobas auto-analyser. 
 
2.5.9 Plasma Tumor necrosis factor (TNF) 
Plasma Tumor necrosis factor (TNF) was assessed using a commercial kit (R&D Systems®, 
MTA00B) according to the manufacturer’s instructions. Briefly, 50 μl of assay diluent were 
added to each well of a 96-well plate. Then, sample (50 μl) or standard were added and 
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incubated at room temperature for 2 hours. The plate was then washed with wash buffer 5 
times and 100 μl of mouse TNF conjugate was added to each well. 100 μl of substrate 
solution was added to each well, and the plate was incubated for 30 min at room temperature 
protected from light. Stop solution (100 μl) was added to each well and the colour developed 
was read with a spectrophotometer (Tecan) at 450 nm and plasma TNF content was 
calculated from a standard curve calculated from a known concentration of this protein (from 
10.9 to 700 pg/mL) and expressed as pg/mL. 
 
2.5.10 Plasma Fibroblast Growth Factor 21 (FGF-21) 
Plasma Fibroblast Growth Factor 21 (FGF-21) was assessed using a commercial kit 
(Abcam®, ab212160) according to the manufacturer’s instructions. On a 96-well plate, 50 μl 
of diluted plasma (1:5 in water) or standard was added to each well. Then, 50 μl of antibody 
cocktail was added and the plates were incubated for 1 hour at room temperature with gentle 
shaking. The plate was washed three times with wash buffer and 100 μl of TMB substrate 
was added to each well, prior to incubation in the dark for 10 min with shaking at 400 rpm. 
Finally, 100 μl of stop solution was added and the plate was kinetically read on a 
spectrophotometer (Tecan) at 600 nm every one minute. At 10 min the assay reached plateau, 
and the absorbance measured at this point was used for calculations. Plasma FGF-21 content 
was calculated from a standard curve developed from known concentration of this protein 
(from 0 to 600pg/mL) and expressed as pg/mL. 
 
2.5.11 RNA extraction, reverse transcription, and real time-qPCR 
Real time-qPCR to determine tissue mRNA levels was performed using standard methods 
(Lo et al., 2011). Total RNA was extracted from muscle (50-60 mg), adipose tissue (150 mg) 
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and liver (40-50 mg) with TRI reagent (Sigma®, T9424). RNA quantitation and quality were 
determined with a spectrophotometer (Thermo Fisher Scientific, Nanodrop ®, Walthan, MA, 
USA) and considered acceptable if the 260/230 ratio was above 1.8. Reverse transcriptase 
was performed using 1000 ng of RNA, plus 0.5 μl of oligo(dT) (Life Technologies, 18418-
012) at 100 μM, 0.5 μL of random hexamers (Applied Biosystems, Life Technologies, 
N8080127) at 2 μM, and were incubated at 65°C for 5 min. Then, 4.0 μL of 5X first strand 
buffer (Life Technologies, catalog number 18080-093), 0.5 μL of Superscript III reverse 
transcriptase at 200 U/μL (Life Technologies, 18080-093), 2.0 μl of DTT at 0.1 M (Life 
Technologies, 18080-093), and 1.0 μL of dNTP mix each at 10 nM (Bioline, BIO-39025) 
were added and further incubated at 25°C for 10 min, 50°C for 60 min, and at 70°C for 15 
min. Real time-qPCR was performed on 5 μL of cDNA added to 7.5 μL of SensiMix SYBR 
Green (Bioline, QT605-20), 0.5 μL of each primer (forward and reverse) at 10 µM, and 1.5 
μL of ddH2O. Using a thermocycler (Rotor-gene Q, QIAGEN ®, Hilden, Germany) 
amplification, elongation, and extension was conducted using a 3-step procedure as follows: 
95°C for 10 min, then 40 cycles of 10 s at 95°C, 15 s at 60°C, and 20 s at 72°C were 
performed. In each run, a no-template control was included as a negative control, and after 
each run a melt curve was performed to confirm the specificity of our in-house designed 
primers. Results are expressed using the delta-delta Ct method, corrected for the housekeeper 
gene Rpl7L1 for skeletal muscle as previously published (Thomas et al., 2014), NoNo for 
adipose tissue, and Aldolase B (AldoB) for liver. The PCR efficiencies across genes was on 
average 0.95, with a range of efficiencies between 0.87-1.12. The list of primer sequences 
used along with Taqman formats are provided in table 5. I gratefully acknowledge the work 
performed by Miss Linda Ban, who conducted the real time qPCR measurements using 
Taqman technology as part of a collaborative work between PhD projects. 
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Table 5. Primers and Taqman formats used for rt-qPCR 
Gene Forward Reverse 
Glut4 5’-CCAGTATGTTGCGGATGCTAT-3’ 5’-ATCTGGTCAAACGTCCGGC-3’ 
Hexokinase 1 5’-TCGGAGGAACGAATTTCCGAGT-3’ 5’-ACAATGTGATCAAACAGCTCATCC-3’ 
Hexokinase 2 5’-TCCAGACGGTACAGAGAAAGGA-3’ 5’-TCTCTACGCCCCTTCGCTTG-3’ 
Mcp-1 5’-CACTCACCTGCTGCTACTCA-3’ 5’-GCTTGGTGACAAAAACTACAG-3’ 
Adiponectin 5’-CGACACCAAAAGGGCTCAGG-3’ 5’-ACGTCATCTTCGGCATGACT-3’ 
AdipoR1 5’-GCAGACAAGAGCAGGAGTGT-3’ 5’-TTGACAAAGCCCTCAGCGAT-3’ 
Sirt1 5’-AGCGGCTTGAGGGTAATCAA-3’ 5’-GAGTATACCTCAGCACCGTGG-3’ 
Pgc-1ɑ 5'-CTGCGGGATGATGGAGACAG-3' 5'-TCGTTCGACCTGCGTAAAGT-3' 
Ucp2 5’-GGCCTCTGGAAAGGGACTTCT-3’ 5’-TTGGCTTTCAGGAGAGTATCTTT-3’ 
Tnf 5'-GACCCTCACACTCACAAACCA-3' 5'-ACAAGGTACAACCCATCGGC-3' 
Col6a1 5’-GATGAGGGTGAAGTGGGAGA-3’ 5’-CAGCACGAAGAGGATGTCAA-3’ 
Ucp1 5'-CATGGGATCAAACCCCGCTA-3' 5'-ATTAGGGGTCGTCCCTTTCC-3' 
Rpl7L1 5’-ACGGTGGAGCCTTATGTGAC-3’ 5’-TCCGTCAGAGGGACTGTCTT-3’ 
NoNo 5'-TGCTCCTGTGCCACCTGGTACTC-3' 5'-CCGGAGCTGGACGGTTGAATGC-3' 
Col1a1 5’-GCTGCACGAGTCACACCGGAA-3’ 5’-GCAGGCGGGAGGTCTTGGTG-3’ 
Col4a1 5’-AGCGAGATGTTCAAGAAG-3’ 5’-TGGACAGTGAGGTACACA-3’ 
Ctgf/CCN2 5‘-GAGTGTGCACTGCCAAAGATG-3’ 5’-TCCAGGCAAGTGCATTGGT-3’ 
Tgf-beta 5’-ACCGCAACAACGCCATCTAT-3’ 5’-TGCTTCCCGAATGTCTGACG-3’ 
Decorin 5’-AGATCACCAAGCTGCGGAAA-3’ 5’-CGCCCAGTTCTATGACAAGCA-3’ 
Mmp2 5’- AACGGTCGGGAATACAGCAG-3’ 5’- GTAAACAAGGCTTCATGGGGG-3’ 
Mmp14 5’-GATAAGCCCAAAAACCCCGC-3’ 5’-CCAGAACCATCGCTCCTTGAA-3’ 
Timp1 5’-CACAAGTCCCAGAACCGC-3’ 5’-GGATTCCGTGGCAGGC-3’ 
Timp2 5’-TCGAGTTTATCTACACGGCCC-3’ 5’-TCTGCCTTTCCTGCAATTAGA-3’ 
Timp3 5’-CTTCTGCAACTCCGACATCGTGAT-3’ 5’-CAGCAGGTACTGGTACTTGTTGAC-3’ 
Des 5’-AGGAGGAGATCCGACACCTAAA-3’ 5’-GATAGGAAGGTTGATCCTGCTC-3’ 
Casp3 5’-CTTCATCATTCAGGCCTGCCG-3’ 5’-CAGCCTCCACCGGTATCTTC-3’ 
MuRF1 5’-CAGAGTGACCAAGGAGAATAGCC-3’ 5’-GATGGCGTAGAGGGTGTCAAA-3’ 
Atrogin 1 5’-TCACAAAGGAAGTACGAAGGAGCG-
3’ 
5’-ATCCAGGATGGCAGTCGAGAA-3’ 
Rps6kb1 5’-GGTGGAACCTCCCTTTAAGCCTC-3’ 5’-CCTGGTTGGCACTTTCACTGAG-3’ 
 Taqman format 
Ctgf Mm01192932_g1 
Tgf-beta Mm01178820_m1 
Col1a1 Mm00801666_g1 
Col4a1 Mm01210125_m1 
Cxcl10 Mm00445235_m1 
AldoB Mm00523293_m1 
 
2.5.12 Protein analysis by immunoblotting (Western immunoblot) 
The levels of expression of specific proteins was determined in muscle, liver, and in plasma 
by Western immunoblot, using established methods (Tam et al., 2015). In either of skeletal 
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muscle (25-30 mg), or liver (10-15 mg) tissue was homogenized in ice-cold buffer containing 
50nM Tris HCl, 150nM NaCl, 1% Triton X-100, 0.5% Na-deoxycholate, and 0.1% SDS, plus 
a protease inhibitor cocktail (Sigma®). After 2 h of incubation at 4°C, tissue samples were 
centrifuged at 10000 g for 10 min at 4°C. The supernatant was removed, and the protein 
concentration was quantified using a detergent compatible (DCTM) protein assay (Bio-
Rad®, catalog number 500-113 and 500-114). For both skeletal muscle and liver, 40 μg of 
protein was used for the analysis. For the studies in plasma, 0.5 μL of sample was mixed with 
3.8 μl of loading buffer and 10.7μL of RIPA buffer. All Western immunoblots were 
performed on precast polyacrylamide gradient gels (4-15%) (Bio-Rad®, 4568086) and were 
run until the dye front reached the end of the gel. In addition to the samples each gel 
contained a standard with proteins of molecular weight (Mwt) 10-250 kDa. Once the gels 
were run the proteins contained within the gel were transferred to a nitrocellulose membrane 
(Bio-Rad®, catalog number 1704158) using a Trans-Blot® Turbo™ Transfer System (Bio-
Rad, Hercules, CA, USA). Membranes were then blocked for 1 hour in 5% skim milk in 
buffer (TBST) containing 0.6% Tris HCl w/v, 0.1% Tris-base w/v, 0.6% NaCl w/v, and 
0.05% Tween-20 v/v. Membranes were then washed for 10 min three times with TBST and 
incubated in primary antibodies overnight at 4°C as per the manufacturer’s instructions. 
Membranes were washed as before in TBST, and then incubated with a secondary antibody 
labelled with peroxidase for 1 hour at room temperature. Membranes were then washed with 
TBST and developed with a chemiluminescent substrate (ClarityTM Western ECL substrate, 
Bio-Rad®, catalog number 170-5061) and visualized on a Chemidoc imaging system (Bio-
Rad®, Hercules, CA, USA). Densitometric analysis of the bands was performed using Image 
Lab software (Bio-Rad®, Hercules, CA, USA). Protein loading was confirmed and 
normalized using Ponceau S staining of the whole membrane in each respective experiment. 
A list of primary and secondary antibodies used in this work is provided in table 6. 
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Table 6. List of primary and secondary antibodies, the dilution and conditions used for 
Western immunoblot analysis in this thesis. 
Target 
Protein 
Brand 
(+species in 
which 
generated) 
Catalog 
number 
Dilution 
(Titer used) 
Treatment Expected 
Size 
Collagen IV 
 
Abcam 
(Rabbit) 
Ab6586 
Polyclonal 
1:2500 Reduce 
Not denature 
~200 kDa 
Collagen I 
 
Abcam 
(Mouse) 
Ab6308 
Monoclonal 
1:2500 Reduce 
Not denature 
~100 kDa 
Decorin 
 
Abcam 
(Rabbit) 
Ab175404 
Polyclonal 
1:2000 Reduce 
Not denature 
~40 kDa 
Collagen VI 
 
Abcam 
(Rabbit) 
Ab6588 
Polyclonal 
1:5000 Reduce 
Not denature 
~100 kDa 
TIMP2 
 
Merck 
(Mouse) 
MAB13446 
Monoclonal 
1:1000 Reduce 
Not denature 
~24 kDa 
MMP2 
 
Santa Cruz 
(Mouse) 
Sc-13595 
Monoclonal 
1:1000 Reduce 
Not denature 
~89 kDa 
TGF beta 
 
Abcam 
(Rabbit) 
Ab92486 
Polyclonal 
1:2000 Reduce 
Not denature 
~44 kDa 
CTGF/CCN2 
 
Gene Tex 
(Rabbit) 
GTX124232 
Polyclonal 
1:2000 Reduce 
Not denature 
~34 kDa 
MMP1 
 
Gene Tex 
(Rabbit) 
GTX100534 
Polyclonal 
1:2000 Reduce 
Not denature 
~54 kDa 
TIMP1 
 
Santa Cruz 
(Rabbit) 
Sc-5538 
Polyclonal 
1:1000 Reduce 
Not denature 
~30 kDa 
Atrogin 1 
(Fbx32) 
 
Abcam 
(Rabbit) 
ab198958 
Polyclonal 
1:5000 Reduce 
Not denature 
~42 kDa 
Adiponectin 
 
Gene Tex 
(Rabbit) 
GTX23455 
Polyclonal 
1:2000 Reduce 
Not denature 
~30 kDa 
Adiponectin 
receptor 1 
Gene Tex 
(Rabbit) 
GTX32425 
Polyclonal 
1:2000 Reduce 
Not denature 
~37 kDa 
Caspase 3 
 
Cell 
Signaling 
(Rabbit) 
9662S 
Monoclonal 
1:1000 Reduce 
Not denature 
~25-35 
kDa 
 
2.5.13 Total matrix metalloproteinase (MMP) and superoxide dismutase (SOD) activity 
in skeletal muscle 
A commercially available kit was used to measure endogenous total MMP activity (Abcam®, 
Ab112146). For this analysis, the protein concentration for assay of total MMP activity was 
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determined in muscle at different protein concentrations (from 0.93 to 7.4 μg/μl). This 
analysis (Figure 5) showed that 50 μl of muscle lysates with a protein concentration of 3 
μg/μl were optimal. The MMP activity was then measured in a black 96-well plate. The 
samples plus an equal volume of MMP green substrate were incubated for 30 min at room 
temperature. MMP activity was then kinetically read spectrophotometrically (Tecan), and the 
fluorescence intensity was measured at Ex/Em = 490/525 nm. The measurement used for 
calculation was obtained after 10 min where the fluorescence reading reached its peak. MMP 
activity was expressed as relative fluorescence unit (RFU) per μg/μl of protein.  
 
 
Figure 5. Standard curve of skeletal muscle protein concentration vs. endogenous MMP 
activity (RFU: relative fluorescence unit). 
 
For cytosolic-mitochondrial SOD activity measurements, a commercially available kit was 
used (Sigma, 19160), where 20 μl of muscle lysate was mixed with 200 μl of 1:20 v/v water-
soluble tetrazolium salt (WST-1) solution that was enzymatically induced for the 
development of formazan dye derived from superoxide production. SOD activity was 
therefore calculated by decrease in the colour development (440 nm) using a sample blank 
control as maximum dye production, normalized per μg/μl of total protein of each sample. 
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2.5.14 Haematoxylin-eosin and Picrosirius red staining 
To investigate the skeletal muscle structure and morphology, samples were prepared for 
histologically analysis as follows. After harvesting tissues from the animals, they were 
submerged in 10% phosphate buffered formalin (pH=7) for 24 hr. When embedding the 
samples in paraffin, efforts were made to position the tissue facing its cross-sectional side to 
the external side of the block. This was followed in order to obtain a clean view of the muscle 
structure. From these paraffin-embedded blocks, 5 μm sections were cut, deparaffinated and 
rehydrated using the following protocol:  
• The slides were incubated in an oven at 60°C for 30-60 min to melt the paraffin. 
Afterwards, the rehydration of the slides was obtained through this procedure: 
 
Table 7. Protocol of deparaffination. 
Solution Time (min) 
Xylene (1) 10 
Xylene (2) 10 
100% EtOH (1) 2 
100% EtOH (2) 2 
95% EtOH (1) 2 
95% EtOH (2) 2 
70% EtOH 2 
Tap water 2 
 
To analyse tissue general structure, slides were stained with haematoxilin-eosin staining as 
follows:  
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Table 8. Haematoxilin-eosin staining protocol 
Solution Time (min) 
Harris’s haematoxilin 2 
Tap water 3 
Acidified ethanol 10 quick dips 
Tap water 3 
Scott’s blueing solution 0.5 
Tap water 2 
70% EtOH 1 
Eosin (1) 0.6 
Eosin (2) 0.6 
95% EtOH (1) 1 
95% EtOH (2) 1 
100% EtOH (1) 1 
100% EtOH (1) 1 
Place slides in oven for 5 min for the ethanol to dry 
Xylene 5 
Mount with DPX adhesive 
 
To investigate the global muscle and collagen structure and distribution, rehydrated slides 
were stained with Picrosirius red (PSR) staining as follows:  
 
Table 9. Picrosirius red staining protocol 
Solution Time (min) 
Harris’s haematoxilin 10 
Tap water 3 
Picrosirius red solution 60 
0.1% HCl acidified 
water 
3 quick dips 
95% EtOH (1) 1 
95% EtOH (2) 1 
100% EtOH (1) 1 
100% EtOH (1) 1 
Place slides in oven for 5 min for the ethanol to dry 
Xylene 5 
Mount with DPX adhesive 
 
Quantification of red staining in each slide (indicative of collagen) was obtained through the 
image processing software Fiji® (Schindelin et al., 2012). For each sample, images from 
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different sectors of the slide were taken, in order to cover the whole tissue. Each of these 
images were loaded into the software individually, and the intensity of red staining was 
quantified by setting the colour threshold with the following characteristics: 
 
• Hue: 0-15 arbitrary units 
• Saturation: 60-255 arbitrary units 
• Brightness: 0-255 arbitrary units 
 
Finally, the results of the different images of the same sample were averaged and that number 
was used for calculations and analysis. 
 
2.5.15 Immunohistochemistry 
Immunohistochemistry was also undertaken using published methods (Martinez-Huenchullan 
et al., 2018a). Specifically, samples were fixed in 10% phosphate buffered formalin for 24 
hours then changed to 80% EtOH (v/v) for overnight processing at the Histopathology 
Laboratory at the Charles Perkins Centre, University of Sydney. From the paraffin-embedded 
blocks, 5μm sections were deparaffinized and rehydrated as described before (Section 
2.5.14). Afterwards, heat-mediated antigen retrieval was performed by heating the slides in 
citrate buffer (pH=6.0) for 30 min in a microwave. After leaving the slides at room 
temperature for 20 min to cool down, they were washed in distilled water. Circles around the 
tissue were drawn with a hydrophobic pen, so the reagents formed ponds when added. Tris-
buffered saline plus tween 20 (TBST) was added to the slides for 5 min. For intracellular 
proteins, the slides were incubated with TBST plus 0.2% Triton X-100 for 10 min to 
solubilize the plasmatic membrane. Then, a double blocking step was performed, where first 
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3% H2O2 in TBS was added for 5 min, then the slides were blocked for 30 min with 1% 
bovine serum albumin (BSA) diluted in TBST. After discarding 1% BSA but without rinsing 
the slides, relevant primary antibodies were added at the recommended titer, and the slides 
were incubated at 4°C overnight. After peroxidase-labelled antibody incubation for 30 min at 
room temperature, colorimetric staining was achieved using avidin-biotin complex 
(Vectastain ABC kit, Vector Laboratories®, catalog number PK-4000) at room temperature 
for 30 min, and later diaminobenzidine (DAB) (Dako®, catalog number K3468) for 10 min. 
The reaction was terminated by washing the slides in ddH2O. The antibodies used in this 
procedure and their dilution are listed in Table 10 below. 
 
Table 10. List of antibodies and dilutions used for immunohistochemical staining. 
Antibodies Brand and species 
in which generated 
Catalog Number Final Dilution (in 
TBS) 
Collagen I 
(Primary antibody)  
Abcam 
(Mouse monoclonal) 
Ab6308 1:500 
Collagen VI 
(Primary antibody)  
Abcam 
(Rabbit polyclonal) 
Ab6588 1:500 
Adiponectin 
(Primary antibody)  
Gene Tex 
(Rabbit polyclonal) 
GTX23455 1:500 
Adiponectin receptor 1 
(Primary antibody)  
Gene Tex 
(Rabbit polyclonal) 
GTX32425 1:500 
Uncoupling protein 1 
(Primary antibody)  
Abcam 
(Rabbit polyclonal) 
ab10983 1:500 
Anti-rabbit peroxidase 
labelled IgG 
(Secondary antibody) 
Vectastain 
(Goat anti rabbit 
polyclonal) 
BA-1000 1:200 
Anti-mouse peroxidase 
labelled IgG 
(Secondary antibody) 
Vectastain 
(Goat anti-mouse 
polyclonal) 
BA-9200 1:200 
 
2.5.16 Statistical analysis 
Statistical analyses were performed using GraphPad Prism Software Version 7.0. Normally 
distributed data were expressed as mean ± SD. Non-normally distributed data were expressed 
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as median [interquartile range]. Effects of dietary and/or metabolic interventions (CHOW vs 
HFD and CHOW vs Diabetes ± HFD) and the differences between exercise conditions 
(untrained vs END vs HIIT) were calculated using a one-way ANOVA with Tukey’s post-
hoc analysis, or two-way ANOVA analysis with Holm-Sidak’s and Tukey’s post-hoc tests. P 
values <0.05 were considered statistically significant. 
 
2.5.17 Utility and reliability of non-invasive muscle function tests in high-fat-fed mice 
(paper published) 
  
97 
 
 
 
 
 
  
98 
 
 
 
  
99 
 
 
 
  
100 
 
 
 
  
101 
 
 
  
102 
 
 
  
103 
 
 
Chapter 3 
Differential metabolic effects of constant moderate versus high 
intensity interval training in high-fat fed mice: possible role of 
adiponectin 
 
Physical exercise is one of the most prescribed lifestyle modification strategies to help 
prevent the development of obesity-related metabolic impairments. Given the several 
parameters that are involved in exercise prescription, exercise programs can be designed in 
such manner that they can confer specific benefits in healthy conditions (for example, in 
athletes). 
In human obesity or in animal models that mimic this condition, comparison between 
different exercise programs that do not differ in terms of distance covered per session, 
number of sessions per week, average intensity, and time per session (i.e. theoretically 
isocaloric) are scarce, therefore it is not possible to reach definitive conclusions from the 
literature available, particularly in terms of skeletal muscle metabolic adaptations. Moreover, 
the recently described endocrine feature of skeletal muscle has been suggested to be a key 
mechanism integral to the classically described exercise-related benefits in metabolic disease, 
particularly muscle adiponectin induction. Thus, the objective of this chapter was to 
investigate the effect of 10 weeks of two similar exercise training programs (in terms of 
distance covered per session, number of sessions per week, average intensity, and time per 
session), namely constant-moderate training, and high-intensity interval training, on the 
expression of muscle adiponectin and related metabolic outcomes, in a mouse model of diet-
induced obesity. The data generated including skeletal muscle structure and function, the 
analyses, and results interpretation with discussion, is provided in the following publication:  
104 
 
 
Differential metabolic effects of constant moderate versus high intensity interval 
training in high-fat fed mice: possible role of muscle adiponectin (Martinez-
Huenchullan et al., 2018a).  
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Chapter 4 
Skeletal muscle adiponectin induction depends on diet, muscle 
type/activity, and exercise modality in C57BL/6 mice  
 
As described in the previous chapter, exercise modalities induce differential metabolic 
benefits in high-fat diet fed mice, even when these effects were not related to a differential 
effect on body composition or on body weight. 
Considering that one of the possible explanations behind the differential effect of constant-
moderate vs high-intensity interval training is the ability of the former to more effectively 
induce HMW muscle adiponectin in quadriceps, a key follow-up question is to determine 
whether this response is homogenous across different skeletal muscles. This questioning is 
supported by the findings reported by Krause et al. (Krause et al., 2008) where they identified 
that some muscle fibres contained higher levels of adiponectin, such as fibres type IIA and 
IIB, which contained higher levels of intramyocellular lipids. Their finding suggests that 
muscles that depend heavily on fat oxidation for energy production (i.e. aerobic metabolism) 
produce adiponectin in a preferable way. Moreover, there are no known studies that have 
explored the influence of exercise itself on muscle adiponectin induction across exercising 
and non-exercising muscles.  
Therefore, in this chapter I took report experiments where I compared the muscle adiponectin 
profiles across three muscles with different characteristics, from the same animals described 
in the studies reported in Chapter 3. Quadriceps is a mixed (aerobic/anaerobic) exercising 
muscle (in mice is somewhat similar to soleus (Jacobs et al., 2013) which has around 40% of 
type I fibres (Augusto et al., 2004)), gastrocnemius is an anaerobic exercising muscle (only 
~6% of type I fibres and more than 50% type IIB fibres (Augusto et al., 2004)) , and masseter 
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(cheek) is an anaerobic non-exercising muscle (100% of type II fibres (Tuxen and Kirkeby, 
1990)). This study is represented by the following publication: 
Skeletal muscle adiponectin induction depends on diet, muscle type/activity, and 
exercise modality in C57BL/6 mice (Martinez-Huenchullan et al., 2018b). 
 
Figure 6. Summary of the findings of Chapter 4. LMW: low-molecular weight adiponectin; 
HMW: high-molecular weight adiponectin. 
Quadriceps (muscle with higher oxidative fibres), were more susceptible to a decrease in 
HMW adiponectin content, whereas exercise normalized this change. In contrast, 
Gastrocnemius and masseter demonstrated increases in the less bioactive isoform of 
adiponectin (LMW) in untrained HFD mice. Moreover, masseter (as a non-exercised muscle) 
did not exhibit HMW adiponectin, suggesting that this isoform could be dependent on the 
muscle activity. 
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Chapter 5 
Constant-moderate and high-intensity interval training have 
differential benefits on insulin sensitive tissues in high-fat fed 
mice  
 
The previous chapters (3 and 4) described the differential metabolic effects on skeletal 
muscle conferred by END and HIIT in high-fat diet fed mice. The animals began the 
interventions in a healthy (i.e. lean) condition, which allowed me to assess the preventive 
effect of these exercise programs. In this context, the possible role of muscle adiponectin 
induction was described and discussed, along with the differential muscle adiponectin 
profiles between exercising and non-exercising muscles, in addition to comparisons between 
glycolytic and more oxidative muscle groups. 
In this chapter, the scope is wider and complementary to what has been described in this 
thesis. Here, the treatment (rather than preventive) effect of END and HIIT is explored by 
analysing the metabolic effects of these training programs in obese animals (after 10 weeks of 
high-fat feeding). However, not only is skeletal muscle analysed, white adipose tissue 
(subcutaneous) and liver are also explored, in order to provide a global metabolic perspective 
regarding the effects of these isocaloric exercise programs, particularly on insulin-sensitive 
tissues. The data generated including skeletal muscle structure and function, the analyses, and 
results interpretation with discussion, is provided in the following publication:  
Constant-moderate and high-intensity interval training have differential benefits on 
insulin sensitive tissues in high-fat fed mice. 
The experiments performed by Miss Linda Ban (e.g. real time qPCR using Taqman 
technology and liver histology), are gratefully acknowledged. 
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Chapter 6 
Differential effects of diabetes and high-fat diet on the skeletal 
muscle extracellular matrix of C57BL/6 mice  
 
The previous chapters have been focused on investigating the effects of obesity and different 
exercise modalities on the function and structure of skeletal muscle. More specifically, 
chapter 5 addressed the ability of exercise regimens in the presence and absence of high fat 
feeding, to affect circulating (endocrine) adiponectin, along with the coordinated metabolic 
adaptations occurring in insulin sensitive tissues of muscle, white adipose tissue and liver. In 
addition, metabolic impairments also have been associated with structural deficiencies in 
skeletal muscle, where disturbances in its ECM have gained special interest in recent years. 
Classically, skeletal muscle ECM was believed to have mainly mechanical functions, 
particularly associated with force transmission from sarcomeres to tendon and joints in order 
to produce movement (Gillies and Lieber, 2011). Typical functions attributed to skeletal 
muscle ECM were related to bedding and sheltering of satellite cells, which are mainly 
responsible for muscle regeneration after injury (Sanes, 2003). However, recent studies have 
highlighted that this structure is highly dynamic, with changes occurring in ECM 
composition depending on different levels of mechanical challenge (for example, physical 
inactivity, exercise), which may associate with muscle dysfunction. In this context, obesity 
and diabetes have been described as causes of skeletal muscle ECM disruption, however the 
literature available is limited and variable in terms of study design, and therefore results. It is 
of particular interest that the influence of hyperglycaemia and obesity on skeletal muscle 
ECM has not been systematically investigated, and therefore the aim of this chapter was to 
elucidate the specific effects of diabetes and obesity (i.e. high fat diet) on skeletal muscle 
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ECM structure. The data generated including skeletal muscle structure and function, the 
analyses, and results interpretation with discussion, is provided in the following publication: 
Effects of diabetes and obesity on skeletal muscle extracellular matrix in mice . 
The housing and feeding of the animals used in this chapter, which were conducted by Miss 
Linda Ban, are gratefully acknowledged.  
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ABSTRACT 
Diabetes and obesity may separately and/or synergistically affect the composition of skeletal 
muscle extracellular matrix (ECM), although chronic models of these metabolic insults are 
lacking. We investigated the effect of long term diabetes and obesity on the skeletal muscle 
ECM in mice. Five week-old male C57BL/6 mice were randomly allocated to receive 
standard chow (n=12) or high-fat diet (HFD;45% kcal fat; n=11) for 30 weeks. An additional 
group of chow-fed and HFD mice were rendered diabetic (3x65mg/kg I.P. streptozotocin) for 
the final 15 weeks (DM; n=14, HFD+DM; n=14). Diabetes was achieved in DM mice (blood 
glucose=~14 mmol/L; p<0.05), whereas HFD induced an increase in plasma insulin and 
muscle triglyceride (p<0.05). Both conditions decreased quadriceps weight and grip strength 
(p<0.05). Muscles of DM mice showed protein increases in connective tissue growth factor 
(CTGF)/CCN2 (1.5-fold; p<0.05), tissue inhibitors of matrix metalloproteinases (TIMP) 1 (2-
fold; p<0.05), and collagen-I (3-fold; p<0.05), -IV (2-fold; p<0.05), and -VI (2-fold; p<0.05). 
In contrast, HFD induced a downregulation of CTGF/CCN2 (0.6-fold; p<0.05), matrix 
metalloproteinase 1 (0.6-fold; p<0.05), and TIMP2 (0.4-fold; p<0.05). Moreover, DM mice 
exhibited increased caspase 3 expression (protein; 1.5-fold; p<0.05), whereas HFD reduced 
the expression (0.5-fold; p<0.05) of caspase 3 and atrogin 1. Furthermore, HFD induced a 
mRNA downregulation of serine/threonine kinase Rps6kb1 (0.75-fold; p<0.05). Notably, in 
HFD+DM mice an intermediate phenotype was observed. These data suggest that diabetes 
and HFD differentially affect skeletal muscle ECM, where diabetes promotes a pro-fibrotic 
profile and HFD impairs regulatory ECM and protein turnover pathways, with both inducing 
muscle dysfunction. 
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INTRODUCTION 
Skeletal muscle extracellular matrix (ECM) is a highly organized structure comprised of three 
components: epimysium (whole muscle), which is mainly composed of fibrillar collagen 
(such as type I); perimysium (muscle fascicles), which is a mixture of fibrillar and network 
collagen (such as type IV and VI); and endomysium (muscle fibre) which is composed 
mainly of network collagens (Frontera and Ochala, 2015, Gillies and Lieber, 2011). The 
ECM’s function includes regeneration (Sanes, 2003) and adaptation to different levels of 
muscle load (Miller et al., 2005). As regulators of this structure, growth factors, 
proteoglycans (PGs), matrix metalloproteinases (MMPs) and their inhibitors known as tissue 
inhibitors of matrix metalloproteinases (TIMPs), play a key role in maintaining ECM 
homeostasis and turnover (Martinez-Huenchullan et al., 2017a). 
In the last decade, a growing body of evidence has demonstrate that during metabolic stress, 
skeletal muscle ECM remodelling occurs which affects the mechanical and metabolic 
features of the muscle (Lark and Wasserman, 2017). Previous studies have concluded 
subsequent to lipid infusions (Richardson et al., 2005), overfeeding periods (Tam et al., 
2014), and in obese insulin-resistant patients (Berria et al., 2006), skeletal muscle ECM 
transcription and translation outputs broadly increase, causing changes that are mainly 
characterized by an accumulation of muscle collagen. Modifications in the skeletal muscle 
ECM have a profound impact on the function of this tissue (Kaasik et al., 2011), given that it 
has been previously described that skeletal muscle ECM has direct roles in several cellular 
processes, such as caspase activation (Mukasa et al., 1999), and ubiquitin labelling (Urso et 
al., 2006), both involved in maintaining a balanced protein turnover in this tissue. 
The mechanisms behind such remodelling of ECM are unclear, and studies using animal 
models, mainly in rodents, have attempted to address them. However, the variability in the 
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length of dietary interventions (often short duration) and differing diet compositions (Tam et 
al., 2015, Biga et al., 2013, Inoue et al., 2013, Kang et al., 2011) have made it difficult to 
compare results. Moreover, the commonly utilised C57BL/6 mice are resistant to developing 
fasting hyperglycaemia and diabetes even after long periods of ingesting a high-fat diet 
(HFD) (Williams et al., 2014), and yet diabetes is a key feature of metabolic disturbances, 
which has been implicated as one of the responsible factors mediating ECM changes in 
skeletal muscle (D'Souza et al., 2013). The pharmacological induction of diabetes, for 
example by using low-dose streptozotocin (STZ), as we have previously developed in our 
laboratory’s model of high fat diet and low dose STZ diabetes induction to examine relevant 
insulin sensitive tissues such as liver (Lo et al., 2011), may be an appropriate model to 
examine these phenomenon. 
To address these limitations, we established a rodent model of chronic high-fat feeding 
leading to obesity and STZ-induced diabetes to investigate the effect of these treatments - 
either alone or in combination - on the phenotype of skeletal muscle. Outcomes included 
quadriceps muscle ECM remodelling, markers of protein turnover, and related muscle 
dysfunction. 
 
MATERIALS AND METHODS 
The study was approved by the Royal Prince Alfred Research Ethics and Governance Office 
(Protocol #2015/024). The experiments described herein were carried out according to the 
guidelines laid down by the New South Wales Animal Research Act 1985 and the 8th Edition 
of the Australian code for the care and use of animals for scientific purposes. 
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Animal characteristics 
Fifty-one 5-week old male C57BL/6 mice were used in this study (Animal Resources Centre, 
Perth, Australia). After one week of housing acclimation, mice were randomly allocated to 
two dietary groups and fed either a HFD (45%kcal fat; n=25) prepared in-house (Lo et al., 
2011), or standard laboratory chow (CHOW; 12%kcal fat; n=26) (Premium rat & mouse 
pellets, Gordon’s Specialty Feeds ®, NSW, Australia), ad libitum for a total of 30 weeks. 
After the first 15 weeks of feeding, a sub-group of each dietary condition were rendered 
diabetic by intraperitoneal injections of low-dose STZ (three consecutive days, 65 mg/kg 
each day), namely DM (n=14) and HFD+DM (n=14). All animals continued on their 
respective diet for a further 15 weeks. Thus from 15 to 30 weeks duration, four groups of 
mice were maintained and studied with n=11-14 per group: CHOW fed controls, DM alone 
fed with normal chow, HFD alone, and HFD+DM. Subsequently, mice were euthanized 
under isoflurane anaesthesia by exsanguination through cardiac puncture, and blood and 
quadriceps muscle were collected for later analysis. 
Animal phenotyping 
Body weight (g) was measured weekly until termination. In the penultimate week, after 4 
hours of fasting, a small drop of blood (approx. 2μl) obtained via a nick in the tail vein of 
each mouse was collected to measure blood glucose using a standard glucose meter 
(FreeStyle Lite, Abbott Diabetes Care, Alameda, CA, USA). Plasma insulin was assessed 
using a commercially available kit (Merck®, catalog number EZRMI-13K). To characterize 
the effects of hyperglycaemia and HFD on skeletal muscle function in the mice, we measured 
the maximum strength through a non-invasive test, namely grip strength. For this, a Chatillon 
DFIS 2 Force Gauge was used as previously described by our group (Martinez-Huenchullan 
et al., 2017b), where each test was performed three times with a 60 s rest between trials. The 
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mean of these three trials was used for the analysis (Bonetto et al., 2015, De Luca, 2014). To 
quantify muscle triglyceride (TAG) content, lipids were extracted from approx. 10mg of 
muscle by the chloroform-methanol (2:1) method and measured using a Roche® TAG 
reagent (Roche, catalog number 11876023). Muscle TAG content was calculated according 
to a standard curve and expressed as mg/mL per mg of tissue. 
RNA extraction, reverse transcription, and real time-qPCR. 
Total RNA was extracted from muscle (50-60mg) with TRI reagent (Sigma®, catalog 
number T9424). RNA yield and quality were measured with a spectrophotometer (Thermo 
Fisher Scientific, Nanodrop ®, Walthan, MA, USA) and considered acceptable if the 260/230 
ratio was above 1.8. cDNA synthesis was performed using 1000ng of RNA, oligo(dT) (Life 
Technologies, catalog number 18418-012) and Superscript III reverse transcriptase (Life 
Technologies, catalog number 18080-093). Real time-qPCR was performed using SensiMix 
SYBR Green (Bioline, catalog number QT605-20) with a Rotor-gene Q thermocycler 
(QIAGEN ®, Hilden, Germany). In each run, a no-template control was included as a 
negative control, and after each run a melt curve was performed to confirm the specificity of 
our in-house designed primers (Ye et al., 2012). Results are expressed using the delta-delta Ct 
method, correcting values to the housekeeper gene Rpl7L1, as previously published (Thomas 
et al., 2014). A list of primer sequences is given in Supplementary table 1. 
Supplementary table 1. Primers used for rt-qPCR. 
Gene Forward Reverse 
Col1a1 5’-GCTGCACGAGTCACACCGGAA-3’ 5’-GCAGGCGGGAGGTCTTGGTG-3’ 
Col4a1 5’-AGCGAGATGTTCAAGAAG-3’ 5’-TGGACAGTGAGGTACACA-3’ 
Col6a2 5’-GATGAGGGTGAAGTGGGAGA-3’ 5’-CAGCACGAAGAGGATGTCAA-3’ 
Ctgf/CCN2 5‘-GAGTGTGCACTGCCAAAGATG-3’ 5’-TCCAGGCAAGTGCATTGGT-3’ 
Tgfb1 5’-ACCGCAACAACGCCATCTAT-3’ 5’-TGCTTCCCGAATGTCTGACG-3’ 
Decorin 5’-AGATCACCAAGCTGCGGAAA-3’ 5’-CGCCCAGTTCTATGACAAGCA-3’ 
Mmp2 5’- AACGGTCGGGAATACAGCAG-3’ 5’- GTAAACAAGGCTTCATGGGGG-3’ 
Mmp14 5’-GATAAGCCCAAAAACCCCGC-3’ 5’-CCAGAACCATCGCTCCTTGAA-3’ 
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Timp1 5’-CACAAGTCCCAGAACCGC-3’ 5’-GGATTCCGTGGCAGGC-3’ 
Timp2 5’-TCGAGTTTATCTACACGGCCC-3’ 5’-TCTGCCTTTCCTGCAATTAGA-3’ 
Timp3 5’-CTTCTGCAACTCCGACATCGTGAT-3’ 5’-CAGCAGGTACTGGTACTTGTTGAC-3’ 
Des 5’-AGGAGGAGATCCGACACCTAAA-3’ 5’-GATAGGAAGGTTGATCCTGCTC-3’ 
Mcp-1 5’-CACTCACCTGCTGCTACTCA-3’  5’-GCTTGGTGACAAAAACTACAG-3’ 
Ppargc1a 5'-CTGCGGGATGATGGAGACAG-3' 5'-TCGTTCGACCTGCGTAAAGT-3' 
Casp3 5’-CTTCATCATTCAGGCCTGCCG-3’ 5’-CAGCCTCCACCGGTATCTTC-3’ 
MuRF1 5’-CAGAGTGACCAAGGAGAATAGCC-3’ 5’-GATGGCGTAGAGGGTGTCAAA-3’ 
Atrogin 1 5’-TCACAAAGGAAGTACGAAGGAGCG-3’ 5’-ATCCAGGATGGCAGTCGAGAA-3’ 
Rps6kb1 5’-GGTGGAACCTCCCTTTAAGCCTC-3’ 5’-CCTGGTTGGCACTTTCACTGAG-3’ 
Rpl7L1 5’-ACGGTGGAGCCTTATGTGAC-3’ 5’-TCCGTCAGAGGGACTGTCTT-3’ 
 
Protein analysis by immunoblotting, total MMP and superoxide dismutase (SOD) 
activity measurements 
Protein expression of collagen-I, collagen-IV, collagen-VI, connective tissue growth 
factor/CCN2 (CTGF/CCN2), transforming growth factor beta (TGFβ1), decorin, MMP1, 
MMP2, TIMP1, TIMP2, caspase 3, and atrogin 1 were determined in muscle by Western 
immunoblot, using established methods (Tam et al., 2015). Briefly, 25-30mg of quadriceps 
muscle was homogenized in ice-cold radioimmunoprecipitation assay buffer (RIPA). Proteins 
were extracted and quantified using a detergent compatible (DCTM) protein assay (Bio-
Rad®, catalog number 500-113 and 500-114). Then, 40μg of protein was loaded into a 
precast polyacrylamide gradient gel (4-15%) (Bio-Rad®, catalog number 4568086). The 
primary antibodies were incubated overnight at 4°C and were diluted as follows: collagen-I 
1:2500 (mouse monoclonal Abcam, catalog number Ab6308), collagen-IV 1:2500 (rabbit 
polyclonal Abcam, catalog number Ab6586), collagen-VI 1:2500 (rabbit monoclonal Abcam, 
catalog number Ab6588), CTGF/CCN2 1:2000 (rabbit polyclonal GeneTex, catalog number 
GTX124232), TGFβ1 1:2000 (rabbit polyclonal Abcam, catalog number Ab92486), decorin 
1:2000 (rabbit polyclonal Abcam, catalog number Ab175404), MMP1 1:2000 (rabbit 
polyclonal GeneTex, catalog number GTX100534), MMP2 1:1000 (mouse monoclonal Santa 
Cruz, catalog number Sc-13595), TIMP1 1:1000 (rabbit polyclonal Santa Cruz, catalog 
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number Sc-5538), TIMP2 1:1000 (mouse monoclonal Merck, catalog number MAB13446), 
caspase 3 1:1000 (rabbit polyclonal Cell Signaling, catalog number 9662S), and atrogin1 
1:5000 (rabbit polyclonal Abcam, catalog number ab198958). Corresponding secondary 
antibodies labelled with peroxidase (1:10000 Anti-rabbit IgG, Sigma®, catalog number 
S9169; 1:10000 Anti-mouse IgG, Sigma®, catalog number A9044) were used (incubation for 
1 h at room temperature). Protein loading was confirmed and normalized using Ponceau S 
staining of total protein in each respective experiment. Densitometric analysis of the bands 
was performed using Image Lab software (Bio-Rad®, Hercules, CA, USA). For endogenous 
total MMP activity measurement, a commercially available kit was used (Abcam, catalog 
number Ab112146), where 50μl of muscle lysates (with a protein concentration of 3μg/μl) 
were incubated with an equal volume of MMP green substrate for 30 min at room 
temperature. The fluorescence intensity was measured at Ex/Em = 490/525 nm. MMP 
activity was expressed as relative fluorescence unit (RFU) per μg/μL of total protein. For 
cytosolic-mitochondrial SOD activity measurements, a commercially available kit was used 
(Sigma, catalog number 19160), where 20μL of muscle lysates were mixed with 200μL of 
1:20 v/v water-soluble tetrazolium salt (WST-1) that was enzymatically induced for the 
development of formazan dye derived from superoxide production. SOD activity was 
therefore calculated from the decrease in the color development (440 nm) using a sample 
blank control as maximum dye production. Afterwards, colorimetric measurements were 
normalized per μg/μL of total protein of each sample.  
Histology and immunohistochemistry 
From the paraffin-embedded blocks, 5μm sections were stained with Picrosirius red (PSR) to 
investigate global muscle and collagen structure and distribution. Quantification of red 
staining in each slide (indicative of collagen) was obtained through the image processing 
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software Fiji® (Schindelin et al., 2012) setting the colour threshold as follows: hue: 0-15 
A.U.; saturation: 60-255 A.U.; brightness: 0-255 A.U. Immunohistochemistry (IHC) to detect 
collagen-I and collagen-VI in quadriceps muscle was undertaken using standard methods (Lo 
et al., 2011). Briefly, samples were fixed in 10% formalin for 24 h then changed to 80% 
EtOH (v/v) for overnight processing at the Histopathology Laboratory at the Charles Perkins 
Centre, University of Sydney. Collagen-I and collagen-VI staining was performed following 
antigen retrieval (microwave in pH 6.0 citrate buffer for 30 min). Primary antibodies against 
collagen-I (1:500 mouse monoclonal Abcam, catalog number Ab6308) and collagen-VI 
(1:500 rabbit monoclonal Abcam, catalog number Ab6588) were incubated with sections 
overnight at 4°C. After secondary antibody incubation for 30 min (1:200, Biotinylated anti-
rabbit IgG, Vector Laboratories®, catalog number BA-1000, and Biotinylated anti-mouse 
IgG, Vector Laboratories®, catalog number BA-9200) at room temperature, colorimetric 
staining was achieved using avidin-biotin complex (Vectastain ABC kit, Vector 
Laboratories®, catalog number PK-4000) with diaminobenzidine (DAB) (Dako®, catalog 
number K3468). The reaction was terminated by washing the slides in ddH2O. Slides were 
then imaged using an Olympus BX53 microscope, with cellSens microimaging software 
(Olympus, Tokyo, Japan).  
Statistical analysis 
Statistical analyses were performed using GraphPad Prism software Version 7.0. Data were 
expressed as mean ± SD. Differences between conditions (CHOW vs DM vs HFD vs 
HFD+DM) were calculated using a one-way ANOVA analysis with Tukey’s post-hoc test. P 
values <0.05 were considered statistically significant. 
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RESULTS 
Effects of Diabetes and High-Fat Diet on Animal Characteristics 
As described in table 1, diabetes and HFD had opposite effects on body weight and plasma 
insulin in the animals (both parameters were decreased or increased, respectively). 
Interestingly, the combination of both treatments had a compensatory effect, bringing both 
parameters closer to the findings in chow-fed animals. STZ given in consecutive low doses 
was effective in increasing fasting glucose into the diabetic range (≥12mmol/L), which was 
up to two-fold higher compared with non-diabetic animals, whereas the addition of HFD 
mitigated this effect, resulting in lesser elevations in fasting glycaemia but still well above 
non-diabetic chow fed mice. The quadriceps weight was found to be similarly decreased by 
diabetes, HFD, and the combination of both factors, a change that had similar functional 
effects reducing grip strength performance in all experimental groups (p<0.05). As expected, 
HFD was effective in increasing the TAG content in quadriceps (p<0.05), whereas diabetes 
alone did not affect the TAG content. 
Table 1. Animal characteristics at termination. 
Parameter 
CHOW 
(n=12) 
CHOW+DM 
(n=14) 
HFD 
(n=11) 
HFD+DM 
(n=14) 
Body weight (g) 33.3 ± 2.1 30.9 ± 1.9a 51.9 ± 4.2a,b 39.6 ± 8.3a,b,c 
Plasma insulin 
(ng/mL) 
0.99 ± 0.27 0.55 ± 0.16a 4.61 ± 2.53a,b 1.80 ± 1.69b,c 
Fasting glucose 
(mmol/L) 
6.7 ± 1.1 13.6 ± 4.6a 7.5 ± 0.9b 10.0 ± 2.8a,b 
Quadriceps weight 0.24 ± 0.02 0.21 ± 0.02a 0.22 ± 0.02a 0.21 ± 0.03a 
162 
 
 
(g) 
Grip strength (N) 1.96 ± 0.06 1.79 ± 0.07a 1.78 ± 0.06a 1.82 ± 0.09a 
Muscle TAGs 
content (mg/mg 
tissue)* 
0.04 ± 0.03 0.03 ± 0.03 0.18 ± 0.03a,b 0.16 ± 0.03a,b 
 
TAG: triglycerides. a: Different from CHOW, b: Different from DM; c: Different from HFD 
(p<0.05 by One-way ANOVA with Tukey’s post-hoc test). Data are expressed as mean ± SD. 
* Number of animals per group is 5-6. 
 
Muscle Collagen in Diabetic and Obese Conditions 
Total muscle collagen was quantified from images of PSR staining (Figure 1A), and the data 
showed that muscles from diabetic mice had higher levels of collagen compared with obese 
animals (Figure 1B; p<0.05), reflecting induction of a differential muscle phenotype. Muscle 
from diabetic animals fed with HFD did not show any significant changes in this outcome 
(Figure 1B). To further analyse this finding, different types of muscle collagen (-I, -IV, and -
VI) were visualized by IHC and quantitated.  
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Figure 1. Quantification of total muscle collagen. Representative cross-sectional quadriceps 
muscle sections, with picrosirius red staining for each condition (A). Quantitation of 
picrosirius red staining positive for collagen in each group (B). b: Different from DM: same 
letters are indicative of differences between those groups (p<0.05 by One-way ANOVA with 
Tukey’s post-hoc test). Data are presented as mean ± SD, the number of animals in each 
group is 9, size bars indicate 100 μm, and images are at 10X magnification. 
 
Diabetic animals exhibited a higher content of muscle collagen-I (Figure 2A, 2B; p<0.05), 
which was not associated with changes in steady state mRNA transcription (Figure 2C). 
Similar findings were seen in two types of network collagen, where muscle collagen-VI was 
higher in diabetic animals (Figure 2E, 2F; p<0.05), with no changes in mRNA (Figure 2G). 
Similar increases in muscle collagen-IV (protein) were seen in diabetic animals (Figure 2H; 
p<0.05), however, the related specific transcription levels showed an opposite pattern (Figure 
2I). These changes collectively indicate an effect of long term diabetes alone on skeletal 
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muscle post-translational increases in these series of collagens. No relevant changes were 
seen in any collagen type in the other experimental groups. 
 
Figure 2. Muscle collagen content. Representative cross-sections of quadriceps muscle with 
collagen-I (A) and -VI (E) immunohistochemistry determined by immunoperoxidase stain, 
and nuclear counter-staining with haematoxylin. The mRNA (B, F, H) and protein (C, G, I) 
levels of collagen-I, -VI, and -IV with a representative immunoblot below the respective 
graph, are presented. The Ponceau S stain reflects that equal total protein was loaded in the 
gel, per sample lane; a: Different from CHOW (p<0.05 by One-way ANOVA with Tukey’s 
post-hoc test). Data are presented as mean ± SD, the number of animals is 11-14 for mRNA 
and 8-9 for protein data, per group. Size bars indicate 200 μm and images are at 4X 
magnification to aid detection of the collagen type-I, and for collagen-VI size bars indicates 
50 μm and images are at 20X magnification. 
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Muscle Extracellular Matrix Regulators in Diabetic and Obese Conditions 
To investigate the influence of ECM regulators on the previously described muscle collagen 
changes, we quantified the presence of growth factors, decorin, MMPs, and TIMPs. Muscle 
CTGF/CCN2 protein was increased in diabetic animals (p<0.05), whereas HFD induced the 
opposite effect (p<0.05), without any changes in the levels of mRNA in either group (Figure 
3A-B). No significant changes in mRNA or protein measurement were seen in TGFβ1 and 
decorin in any of the experimental groups (Figure 3C-F).  
 
Figure 3. Growth factors and decorin. Connective tissue growth factor (CTGF/CCN2), 
transforming growth factor beta (TGFβ1), and decorin mRNA (A-C-E) and protein (B-D-F) 
levels with its representative immunoblots below the respective graphs; a: Different from 
CHOW; b: Different from DM (p<0.05 by One-way ANOVA with Tukey’s post-hoc test). 
Data are presented as mean ± SD, the number of animals is 11-14 for mRNA and 8-9 for 
protein data, per group. 
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Total muscle endogenous MMP activity did not show differences between the groups (Figure 
4A), however, HFD induced a decrease in MMP1 protein (Figure 4B; p<0.05), a change that 
was not seen for MMP2 (Figure 4C). Interestingly, only diabetic mice showed higher protein 
levels of TIMP1 (Figure 4D; p<0.05), whereas decreases in TIMP2 protein were seen only in 
HFD animals (Figure 4E; p<0.05).  
 
Figure 4. Muscle matrix metalloproteinases (MMPs) and their inhibitors (TIMPs). Total 
quadriceps MMP activity (A), and protein levels of MMP1 (B), MMP2 (C), TIMP1 (D), and 
TIMP2 (E) levels with its representative immunoblots below the respective graphs are shown; 
a: Different from CHOW, b: Different from DM; c: Different from HFD (p<0.05 by One-way 
ANOVA with Tukey’s post-hoc test). Data are presented as mean ± SD, the number of 
animals is 8-9, per group. RFU: relative fluorescence unit. 
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Decreases of Mmp14 mRNA levels were found in diabetic animals whereas no changes were 
seen in Mmp2 (Supplementary Figure 1A-B). The mRNA levels of Timp1 and Timp2 were 
similarly affected by HFD, where both markers showed a significant decrease 
(Supplementary Figure 1C-D; p<0.05), with no changes in Timp3 mRNA levels 
(Supplementary Figure 1E). Collectively, this data suggests that diabetes may induce ECM 
accumulation through TIMP1 protein induction, whereas high fat diet alone does not have 
these effects. 
 
Supplementary Figure 1. mRNA levels of extracellular matrix regulators. mRNA levels of 
matrix metalloproteinase (Mmp) 14 (A), Mmp2 (B), tissue inhibitor of MMP (Timp) -1 (C), -
2 (D), and -3 (E). a: Different from CHOW, b: Different from DM (p<0.05 by One-way 
ANOVA with Tukey’s post-hoc test). Data are presented as mean ± SD, the number of 
animals is 11-14 per group. 
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Muscle Homeostasis Markers Under Diabetic and Obese Conditions 
To assess the impact of diabetes and obesity on muscle homeostasis, we measured the mRNA 
levels of key genes associated with muscle structure and metabolism plus the enzymatic 
activity of SOD. Desmin mRNA levels were similarly decreased by diabetes alone and by 
obesity alone by about 30% (p<0.05), with no synergistic effect between these two conditions 
(Figure 5A). From an inflammation perspective, as expected, diabetes and obesity both 
increased Mcp-1 mRNA levels (~2.5-fold; p<0.05) whereas no significant changes were seen 
in animals where both conditions were induced (Figure 5B). The expected decreases in 
mRNA levels of Pgc-1a were seen in HFD groups (Figure 5C; p<0.05), a finding that agreed 
with the decreases in muscle SOD activity detected in the same animals (Figure 5D; p<0.05). 
 
Figure 5. Muscle homeostasis markers. The mRNA levels of desmin (des; A), monocyte 
chemoattracting protein 1 (Mcp-1; B), peroxisome proliferator-activated receptor gamma 
coactivator 1-alpha (Ppargc1a; C), and quadriceps endogenous superoxide dismutase (SOD) 
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enzymatic activity (D); a: Different from CHOW, b: Different from DM (p<0.05 by One-way 
ANOVA with Tukey’s post-hoc test). Data are presented as mean ± SD, the number of 
animals is 11-14, per group. 
 
Muscle Protein Balance Mediators Under Diabetic and Obese Conditions 
To investigate if the previously described changes in the muscle ECM were accompanied by 
intracellular imbalances, we analysed the behaviour of relevant markers related to muscle 
protein homeostasis. First, we explored transcription levels of caspase 3 which were 
decreased by diabetes, and HFD induced a further reduction although an additive effect of 
these treatments was not observed (Figure 6A; p<0.05). On the other hand, diabetes induced 
an increase in caspase 3 protein, whereas HFD induced a significant reduction, while the 
combination of the two did not change this parameter (Figure 6B; p<0.05). Moreover, the 
mRNA levels of two ubiquitin ligases (also called atrogenes), muscle-specific RING finger 
protein 1 (MuRF1) and atrogin 1, were similarly affected by diabetes and HFD without an 
exacerbation by the combination of both conditions (Figure 6C, 6E; p<0.05). From a protein 
perspective, HFD induced a significant reduction in atrogin 1 (p<0.05) that was not changed 
by the combination of diabetes and HFD (Figure 6D). Finally, to further investigate for 
changes in protein synthesis, we measured the mRNA levels of the effector of the 
mammalian target of rapamycin (mTOR) pathway, ribosomal protein S6 kinase B1 
(Rps6kb1), which was found to be decreased specifically by HFD, with no effect of diabetes 
or the combination of both conditions (Figure 6F; p<0.05). 
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Figure 6. Muscle protein turnover markers. The mRNA levels of caspase 3 (casp3; A), 
atrogin 1 (C), along with its respective protein levels (B, D) are shown along with its 
representative immunoblot below the respective graph. The mRNA levels of muscle RING-
finger protein 1 (MuRF1; E) and Ribosomal protein S6 kinase B1 (Rps6kb1; F); a: Different 
from CHOW, b: Different from DM (p<0.05 by One-way ANOVA with Tukey’s post-hoc 
test). Data are presented as mean ± SD, the number of animals is 11-14 for mRNA and 8-9 
for protein data, per group. 
 
DISCUSSION 
To our knowledge, this is the first report to compare responses of skeletal muscle 
extracellular matrix in diabetic and obese conditions, along with the associated intramuscular 
adaptations. Diabetes induced a fibrotic profile, causing fibrillar and network collagen 
accumulation, a feature that was accompanied by protein increases in CTGF/CCN2, TIMP1, 
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and Caspase 3. In contrast, obesity induced a downregulation of several ECM regulators 
(CTGF/CCN2, MMP1, and TIMP2) along with decreases in Caspase 3, ubiquitination 
(atrogin 1) and mitochondrial (Pgc-1a) markers, whereas an increase in the mRNA levels of 
Mcp-1 was common to both conditions. Interestingly, the combination of both conditions did 
not exacerbate any of these changes seen by either metabolic insult alone, which is in line 
with the phenotypic characteristics of those animals. 
Diabetes and HFD induced the expected phenotypical changes in the animals. Remarkably, 
when these two conditions were combined, the effect was compensatory rather than 
synergistic; for example, lower body weight and plasma insulin than HFD mice, and lower 
levels of fasting glucose than DM animals. Similarly, it has recently been described that STZ-
induced diabetic C57BL/6 male mice fed with HFD for 6 weeks exhibited lower levels of 
blood glucose compared to lean diabetic animals (Carvalho et al., 2018). The mechanisms 
behind this phenomenon are not clear, however, at least partly likely through induction of 
insulin resistance, HFD is known to induce an increase in insulin secretion as in this study. In 
addition, HFD could partially counteract the hypoinsulinemic effect of STZ, which is 
cytotoxic to pancreatic β-cells (Jansen et al., 1996). This compensation might explain the 
milder phenotype found in the HFD+DM animals generally compared with DM alone, 
however, such conjecture warrants further studies. 
Previously it has been described that metabolic disturbances have an impact on skeletal 
muscle ECM (Berria et al., 2006, Kang et al., 2011, Tam et al., 2014, Tam et al., 2015). Here, 
we identified that diabetes and obesity seem to have a differential impact on this structure, 
where long-term hyperglycaemia induced a global increase in muscle collagens, whereas 
HFD induced a decrease in key ECM regulators. To understand the processes that could 
explain this diabetes-related remodelling, we investigated the behaviour of different ECM 
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mediators. For instance, diabetes induced a specific increase in the protein levels of 
CTGF/CCN2, a growth factor previously described as being highly involved in muscle 
dystrophies (Sun et al., 2008, Morales et al., 2011), which itself is a condition characterized 
by an abnormal ECM accumulation. In this context, the decrease in CTGF/CCN2 protein 
seen in muscles from HFD animals might explain the absence in changes in any of the 
collagen types measured, suggesting a compensatory response. Interestingly, another well-
documented growth factor, TGFβ, did not show dysregulation in this model, despite previous 
studies reporting that these two proteins are often tightly coregulated (Grotendorst, 1997, Liu 
et al., 2013). However, it is also well recognized that, depending on the disease condition, 
inciting reagent and model, CTGF and TGFβ can be regulated independent of each other 
(Frara et al., 2018, Brenmoehl et al., 2017, Song et al., 2017), including in skeletal muscle 
(Morales et al., 2013). As another family of ECM regulators, PGs are implicated as being 
highly relevant in skeletal muscle ECM homeostasis given their function as regulators of the 
bioavailability of growth factors, such as TGFβ and CTGF/CCN2 (Brandan and Gutierrez, 
2013). From the PG family, we chose to investigate decorin given that is the most prevalent 
in skeletal muscle (Brandan et al., 1991), however, no major changes in the level of this 
protein were seen in any of the experimental groups.  
Another process of ECM regulation can be found in the balance between MMPs and TIMPs. 
On the one hand, MMPs are a zinc-endopeptidase superfamily of enzymes that have the 
ability to degrade the majority of proteins found in the ECM (Alameddine, 2012), such as 
collagens and proteoglycans. In contrast, TIMPs inhibit the action of MMPs in order to 
regulate the ECM turnover, maintaining balance to the ECM (Visse and Nagase, 2003). In 
our study, diabetes induced an increase in the protein levels of TIMP1, suggesting an 
imbalance in the MMPs/TIMPs equilibrium (that is, the ratio of ECM degradation to 
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accumulation, as a generalization). However, endogenous total MMPs activity was 
unchanged in all experimental conditions, whereas only HFD induced a reduction in the 
protein levels of MMP1 and TIMP2. These changes suggest that diabetes increases the 
availability of growth factors (such as CTGF/CCN2) and TIMP1, which might reduce the 
activity of particular MMPs. This would induce an overall increase in ECM collagen content, 
reflecting a concept which has been previously proposed by our group albeit in other non-
muscle diabetes organ complications models (McLennan et al., 2013). Nevertheless, this 
hypothetical change in MMP activity cannot be confirmed by measuring total endogenous 
MMP activity alone, considering that several MMPs can be found in the skeletal muscle 
(Alameddine, 2012) and they may not act in concert. In contrast, HFD induces a balanced 
downregulation of several ECM regulators (CTGF/CCN2, MMP1, TIMP2), and therefore, no 
ECM accumulation (in the form of fibrillar and/or network collagens) was seen in HFD alone 
mice.  
In this context, most of the ECM changes previously described were not seen in HFD+DM 
animals, suggesting that the compensatory effect that these two metabolic conditions had 
from a phenotypical perspective may protect the muscle from the disturbances associated 
with diabetes or obesity alone. These results suggest that systemic metabolic alterations are 
responsible for the dysregulation of skeletal muscle ECM, and not HFD consumption or the 
STZ injections in isolation. However, further mechanistic studies are needed to fully 
elucidate the association between ECM changes in diabetes and obesity, and how, in skeletal 
muscle, the presence of both may attenuate the findings of one metabolic insult alone. 
Notably, the combination of diabetes induction and high fat diet was shown to induce a more 
severe liver tissue profibrotic change than either metabolic insult alone in the same breed of 
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mice (Lo et al., 2011), reflecting that differential effects of a combined metabolic milieu are 
observed across different organs and tissues. 
To have an approximation of the underlying mechanisms behind the previously described 
effects of diabetes and obesity, several markers of muscle homeostasis were assessed. 
Desmin is an essential intermediate filament that physically connects the sarcomere with the 
sarcolemma and the ECM in skeletal muscles (Hnia et al., 2015), where one of its functions is 
to properly transmit the tension produced at the sarcomere to the sarcolemma and ECM, 
therefore preventing mechanical damage on the tissue (Li et al., 1997). Interestingly, skeletal 
muscles from Desmin KO mice exhibit fibrotic profiles as a consequence of progressive 
tissue damage (Meyer and Lieber, 2012), and lower capacity to produce force (Li et al., 
1997). Correspondingly in our study, diabetes and obesity induced each a significant decrease 
of its mRNA levels, suggesting that the functional (grip strength) and structural changes 
reported here could be associated with disturbances at this level, however, this will require 
further experiments. Diabetes and obesity have been described to induced an inflammatory 
profile in skeletal muscles (D'Souza et al., 2013), therefore we investigated the mRNA levels 
of Mcp-1, a marker that has been associated with inflammation and macrophage infiltration 
in skeletal muscles (Patsouris et al., 2014). As expected, significant increases were found in 
muscles from both diabetic and obese animals, whereas no significant changes were detected 
in the animals affected by both treatments, suggesting that the milder phenotype of this group 
could be modulating this outcome. To validate our dietary intervention, we assessed key 
markers of mitochondrial function and oxidative stress in muscle, outcomes that are known to 
be affected in an obesity context (Heo et al., 2017). Correspondingly, the mRNA levels of 
Pgc-1a and the endogenous cytosolic-mitochondrial activity of SOD were decreased in the 
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animals fed with HFD, highlighting the effectiveness of our model to replicate the expected 
obesity-induced metabolic disturbances in skeletal muscle. 
Given the close relationship of extracellular matrix status with intracellular processes, we 
also investigated the cellular state of outcomes related to protein turnover in skeletal muscle. 
Firstly, we observed a differential effect of diabetes and HFD on caspase 3, where the former 
induced a decrease of its protein levels, whereas the latter induced the opposite change. This 
association between skeletal muscle ECM disturbances and caspase 3 increases has been 
previously described, where gastrocnemius muscles from laminin ɑ2-deficient mice exhibit 
higher levels of caspase 3 activation (Mukasa et al., 1999). Considering our results, higher 
levels of caspase 3 might be responsible for the muscle atrophy detected in our DM animals 
(lower muscle weight), nevertheless, caspase activity measurements should be conducted to 
confirm this statement. Interestingly, HFD promoted the opposite behaviour in this protein, 
suggesting that other markers of protein turnover are involved in this process. Moreover, we 
investigated two distinct ubiquitin ligases in skeletal muscle, MuRF1 and atrogin 1 (Murton 
et al., 2008). DM and HFD each induced a decrease in the mRNA levels of both genes, 
however, only HFD induced a significant reduction in the protein levels of atrogin 1, a 
finding that was unchanged in HFD+DM mice, suggesting a strong influence from HFD 
intake. Given that in HFD animals we also detected signs of muscle atrophy, in order to have 
a clearer perspective of the balance between protein synthesis/degradation, we measured the 
mRNA levels of Rps6kb1 (p70S6k), as a downstream factor of mTOR (Sandri, 2008), which 
is a well-known protein synthesis mediator in skeletal muscle. As expected, HFD induced a 
significant decrease (> 25% compared with CHOW) in this marker, a change that is 
supported by previously published studies. For example, after 24 weeks of high-fat high-
sucrose diet, fractional synthesis rates of muscle protein were decreased in soleus and tibialis 
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anterior muscles of Wistar rats (Masgrau et al., 2012), suggesting that the muscle atrophy 
seen in this group could be related to lower levels of muscle protein synthesis, rather than the 
increased protein degradation implicated in the DM alone group. 
In summary, our results indicate that in skeletal muscle of mice, diabetes induces a fibrotic 
profile with increases in the protein levels of several collagen types along with higher protein 
levels of caspase 3, whereas HFD promotes decreases of several ECM regulators along with 
protein turnover markers. This suggests that long-term hyperglycaemia and HFD induce 
muscle function impairments by different mechanisms. Interestingly, the combination of 
HFD and diabetes did not induce further impairments in the previously described outcomes, 
which could be related to the milder phenotype seen in those animals, and/or some form of 
balanced response of skeletal muscle when each of these metabolic insults co-exist. 
Considering this work, skeletal muscle dysfunction, particularly related to its ECM, is 
predicted to be more overtly recognized as one of the series of diabetes and obesity related 
complications. Further research should be aimed at clarifying the mechanisms behind these 
phenomena, in order to find effective strategies to detect and address related skeletal muscle 
pathological changes in response to specific systemic metabolic stressors.  
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Chapter 7 
General discussion and conclusions 
 
7.1 Rationale behind this work 
Obesity is a global epidemic with well-described metabolic impairments such as 
hyperinsulinaemia and insulin resistance, which in many cases directly impacts quality of life 
at an individual level and population health and related economic cost. Obesity affects 
multiple organs, specially highly metabolic active tissues, such as white adipose tissue, liver 
and skeletal muscle. The full spectrum of mechanisms behind obesity-associated skeletal 
muscle metabolic dysfunction remain unclear. Moreover, physical exercise is one of the most 
prescribed lifestyle modifications that may counteract the development of skeletal muscle 
dysfunction, with mostly generic physical activity recommendations being prescribed such as 
a minimum of 150 minutes of exercise, predominantly as aerobic, but with some resistance, 
at least 3-4 times per week. However, it has been recognised that specific exercise 
characteristics (i.e. type, frequency, duration, intensity) induce specific metabolic benefits, 
which could assist in targeting specific obesity-related metabolic impairments. To date, 
relatively few studies have investigated the differing metabolic benefits of different exercise 
programs on obesity-associated skeletal muscle dysfunction. 
 
Metabolic diseases such as obesity and diabetes, can have detrimental effects not only on 
energy metabolism and related signalling in skeletal muscle, but also on skeletal muscle 
structure, particularly on its ECM. Nevertheless, there have been no studies to date which 
have examined the specific impact of hyperglycaemia and obesity (in the form of high-fat 
diet intake) on ECM remodelling. Examining the role of ECM remodelling on skeletal 
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muscle could aid in the understanding of pathological pathways, and ultimately in the 
development of effective and efficient treatments to counteract such metabolic complications.  
 
For these reasons, the initial aim of this work was to investigate the metabolic effect of two 
isocaloric training programs: moderate-intensity endurance (END) or high intensity interval 
training (HIIT), in a mouse model of diet-induced obesity using a preventive approach. The 
second aim was to compare the effects of two isocaloric programs (HIIT and END) on the 
metabolic function of skeletal muscle, white adipose tissue, and liver of an established obese 
mouse model, using a treatment approach. The third aim was to investigate the effect of long 
term diabetes and obesity on skeletal muscle extracellular matrix of C57BL/6 mice. 
 
7.2 Effects of high-fat diet and exercise on skeletal muscle 
 
7.2.1 Preventive effects of exercise 
The experiments described in chapters 3, 4, and 5 aimed to elucidate the effects of high-fat 
diet and different exercise regimes on the metabolic function of skeletal muscles, white 
adipose tissue and the liver. Initially, the preventive effects of exercise were explored in an 
animal model of diet-induced obesity. This was to test the hypothesis that exercise is able to 
protect skeletal muscle against the metabolic impairments derived from HFD (Lark et al., 
2012) and, if different exercise prescriptions, even isocaloric, may have any different 
protective effects systemically and on a tissue basis. We compared END vs. HIIT given that 
they have clear differences in terms of intensity, which is a known factor that induces 
differential metabolic responses in humans (Bajpeyi et al., 2009). Moreover, these training 
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programs have been previously compared in terms of their metabolic benefits. Interestingly, 
in several studies authors have concluded that there are no major advantages of HIIT over 
END (Fisher et al., 2015, Wewege et al., 2017, Winn et al., 2018). Earlier studies that had 
suggested a superior effect of HIIT compared to END had methodological concerns, such as 
mismatched duration and/or distance covered per exercise session (Linden et al., 2015, Wang 
et al., 2017), factors that undeniably hinder the ability to make valid comparisons between 
training programs. 
 
In this thesis, END and HIIT were designed to be isocaloric, where the total exercise time per 
session, and distance run per animal, were matched between dietary groups. Therefore, valid 
comparisons of the two forms of exercise could be made. In this context, when physical 
exercise and HFD intake were initiated simultaneously, END and HIIT programs showed 
comparable protective effects on systemic metabolism markers such as insulin sensitivity 
(during insulin tolerance test) and circulating ALT levels along with similar muscle-specific 
effects (i.e. preserved muscle strength and lower levels inflammation markers) as shown in 
figure 6. However, END exhibited greater protective features by preventing the expected 
hyperglycaemia and hyperinsulinaemia driven by HFD. As a possible mediator behind these 
differential responses, muscle-derived adiponectin has previously been reported to act as a 
mediator of skeletal muscle metabolism (Iwabu et al., 2010), that specifically targets the 
induction of oxidative pathways to produce energy in skeletal muscle, which are pathways 
that are influenced by aerobic exercise programs, such as END and HIIT. Most of the 
published literature refers to the action of the circulatory form of this protein on skeletal 
muscle, however since 2004 it has been recognized that skeletal muscle cells are able to 
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produce adiponectin (Delaigle et al., 2004) and it has been suggested that its action is at least 
partly through autocrine/paracrine mechanisms (Jortay et al., 2012, Jortay et al., 2010).  
Considering that adiponectin has a carboxyl-terminal globular domain and an amino-terminal 
collagen domain which enables it to form multimers (Pajvani et al., 2003), two main isoforms 
were measured; low-molecular weight (LMW) and high-molecular weight (HMW), where 
the latter has been described as the most biologically active (Waki et al., 2003). In this 
context, END was superior to HIIT by not only preventing the HFD-driven decrease in HMW 
adiponectin in quadriceps, but by increasing it above levels seen in CHOW-untrained mice. 
These changes were associated with normalization of the mRNA levels of key adiponectin 
downstream factors such as Pgc1a and Ucp2 (Liu and Sweeney, 2014). In this context, it has 
been described that the LMW is the usual isoform of adiponectin as it does not require major 
post-translational modifications to achieve this state (Tsao, 2014). In contrast, to form HMW 
complexes, steady intracell pH and redox levels are required (Briggs et al., 2011) factors that 
change under chronic HFD intake. This could be an explanation why we saw this specific 
decrease in muscle HMW adiponectin. 
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Figure 7. Summary of preventive effects of constant-moderate endurance (END) and high-
intensity interval training (HIIT) in high-fat diet fed mice. Changes specifically prevented by 
END and HIIT are highlighted in green and blue, respectively. The presence of both blue and 
green means that END and HIIT each prevented that change similarly. 
 
In light of these results, the possibility that muscle adiponectin could be a relevant mediator 
of the metabolic benefits of END and HIIT is plausible. However, previous studies have 
highlighted that, even when muscle adiponectin can be reproducibly induced by several 
stimuli such as inflammatory cytokines (Delaigle et al., 2004), different levels of mechanical 
loads (Goto et al., 2013), exercise (Dai et al., 2013), and high fat diets (Bonnard et al., 2008, 
Delaigle et al., 2006, Liu et al., 2009, Yang et al., 2006), this response is not consistent across 
different types of skeletal muscle. In this context, higher adiponectin content has been 
reported in muscle fibres with high levels of intramyocellular lipids (particularly fibres IIA 
and IIX) (Krause et al., 2008), suggesting that muscles with oxidative profiles could be 
specifically responsible for producing this protein locally in muscle, possibly as a counter-
regulatory, cellular protective mechanism. We compared the adiponectin profiles of three 
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muscles with different metabolic features (oxidative vs glycolytic; exercised vs non-
exercised) (Figure 7), to investigate if they were similarly susceptible to the action of HFD, 
and to investigate the potential effects of exercise on these processes. As expected, muscle 
with higher oxidative fibres (quadriceps) were more susceptible to a decrease in HMW 
adiponectin content, whereas exercise normalized this change. Interestingly, glycolytic 
muscles (gastrocnemius and masseter) demonstrated increases in the less bioactive isoform 
of adiponectin (LMW), changes that suggest that muscles may attempt to compensate for the 
metabolic impairments driven by HFD by intrinsically increased oxidative pathway 
signalling, which is particularly dependent on adiponectin; this hypothesis needs further 
exploration. In addition, non-exercised muscles (masseter) did not exhibit HMW adiponectin, 
suggesting that this isoform is dependent on the level of mechanical load in muscle, which is 
aligned with what has been described previously in overload and unloading models in mice, 
where muscle adiponectin content is affected by these changes (Goto et al., 2013). Overall, 
muscle adiponectin induction, particularly from exercise, seems to be a local response where 
exercising muscle exhibits change in this parameter. Given the lack of studies in this matter, 
mechanistic studies will be required needed to elucidate the relevance of the novel findings 
described in this thesis across skeletal muscle groups. 
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Figure 8. Summary of the effects of high-fat diet, along with the additive effect of constant-
moderate (END) and high-intensity interval training (HIIT) on skeletal muscle adiponectin 
and its isoforms in mice. Arrows indicate changes in protein levels compared to CHOW 
untrained animals. -- indicates that this isoform was not detectable. LMW: low-molecular 
weight; HMW: high-molecular weight. 
 
7.2.2 Treatment effects of exercise 
Considering that the results previously described can only be extrapolated to scenarios where 
physical exercise is performed by healthy individuals at the same time as commencing a 
high-fat diet, insights regarding the treatment effects of different exercise prescriptions in 
already obese individuals cannot be achieved. This is relevant clinically as a considerable part 
of the population that choose physical exercise as a lifestyle modification to improve 
metabolic health, are already overweight or obese. Moreover, potential benefits of exercise 
are dependent on the metabolic status of the individual that performs it along with the 
functional state of the tissues that are involved in the exercise-related adaptations (Hickner et 
al., 1999, Sakamoto et al., 1993). Therefore, in Chapter 5 obesity was first induced in mice by 
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10 weeks of HFD, and then afterwards 10 weeks of exercise training was commenced. In this 
manner, potential effects of exercise to reverse processes that have become established by 
obesity, could be measured. Considering that in the previous studies (chapters 3 and 4), data 
was exclusive to skeletal muscle, white adipose tissue and liver outcomes were also assessed 
here. This was to obtain a broader understanding of how END and HIIT could have 
differential treatment effects during obesity. 
 
This animal model mimicked the clinical scenario frequently seen after exercise regimens in 
humans. The exercise trained animals consuming HFD did not exhibit significant changes in 
terms of body weight and composition (fat/lean mass), however several physical performance 
components were improved such as aerobic capacity and skeletal muscle strength, suggesting 
that all the metabolic changes described here are body weight loss independent. From a 
tissue-specific perspective, skeletal muscle adiponectin was similarly reduced by HFD 
compared to the results seen in the preventive model, where the levels of HMW isoform were 
also reduced. Interestingly, both END and HIIT were able to reverse this change, without 
significant differences across each other. This suggests that the differential effects between 
END and HIIT on muscle adiponectin induction depends on the metabolic status of skeletal 
muscle, given that in the preventive model all mice started as lean and healthy subjects, 
whereas in the treatment model mice started the exercise regimens already in a metabolically 
impaired condition. It may also be that mice develop muscle adiponectin resistance in the 
weeks prior to the commencement of physical training (Liu and Sweeney, 2014), which may 
explain the lack of differences between END and HIIT effect. Nevertheless, this hypothesis 
requires further exploration given that no major differences in the mRNA levels of 
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adiponectin downstream factors (Pgc1a, Ucp2) were seen after END or HIIT, with only HIIT 
normalizing AdipoR1 protein levels in quadriceps of HFD mice.  
Given that white adipose tissue is susceptible to the metabolic effects of HFD (Rosen and 
Spiegelman, 2006, Sun et al., 2013), potential treatment effects of END and HIIT on 
inflammation, fibrosis, and markers of browning adipose tissue were also assessed. 
Macrophage infiltration in adipose tissue is one of the hallmarks of obesity in this tissue, 
therefore we measured the mRNA of monocyte chemoattractant protein–1 (Mcp-1), a key 
adipokine which is known to mediate adipose tissue inflammation and macrophage 
infiltration (Kanda et al., 2006). As expected HFD increased Mcp-1 mRNA levels in 
subcutaneous white adipose tissue, with both END and HIIT demonstrating similar reversal 
effects, changes that may be associated with the previously described exercise-driven 
attenuation of oxidative stress in adipose tissue during obesity (Sakurai et al., 2017). This 
suggests that exercise intensity may not be relevant for attenuating white adipose tissue 
inflammation during obesity. Considering that inflammation and fibrosis are closely related 
processes in adipose tissue (Buechler et al., 2015), collagen VI, a highly abundant collagen in 
adipose tissue ECM, was assessed in the same fat depot (Pasarica et al., 2009). Both END 
and HIIT conferred similar attenuation of collagen VI accumulation driven by HFD. Another 
process of interest is the capacity of the white adipocytes to undergo browning, where these 
cells acquire brown adipocytes features, such as multilocular lipid droplets and greater 
mitochondrial function (Seale and Lazar, 2009), the latter characterised by increases in 
Uncoupling protein 1 (UCP1) (Kiefer, 2017). Exercise has been proposed to induce browning 
in healthy conditions (Lehnig and Stanford, 2018). Hence, the potential browning effect of 
END and HIIT during obesity was explored in this work. We found that only HIIT increased 
mRNA and protein levels of UCP1 in the subcutaneous fat depot of HFD mice. One possible 
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explanation for this differential effect is that adrenergic stimuli on white adipocytes is a 
recognised factor that induces browning (Mossenbock et al., 2014). Exercise at high 
intensities induces production and liberation of catecholamines such as adrenaline and 
noradrenaline (ACSM, 2016), which during chronic conditions could promote higher levels 
of browning in this tissue, a phenomenon that is not seen during moderate-intensity exercise. 
Unfortunately, these proteins were not quantified during the training sessions. Moreover, 
considering the proposed cross-talk mechanism between skeletal muscle and adipose tissue, 
fibroblast growth factor 21 (FGF21) has been suggested as possible mediator of browning 
(Rodriguez et al., 2017). FGF21 protein levels have been found to be increased in the 
circulation of untrained animals fed HFD as expected (Fisher et al., 2010) and exercise in 
both forms similarly attenuate these changes. 
 
Non-alcoholic fatty liver disease (NAFLD) is one of the most common consequences of 
obesity and metabolic disease. The effectiveness of physical exercise for attenuating NAFLD 
has been increasingly explored in animal and human studies. In animal studies, 
methodological differences between END and HIIT programs in terms of intensities, duration 
of the sessions and distance covered per session in each training program (Cho et al., 2015, 
Wang et al., 2017), has made it difficult to compare the interventions. However, the two 
training programs were isocaloric, similar metabolic benefits have been described in patients 
with NAFLD (Winn et al., 2018). Our animal model was able to reproduce the similar 
benefits of END and HIIT found in clinical studies in terms of attenuation of the HFD-driven 
increase in liver weight, steatosis and markers of liver damage (ALT). Liver ECM 
remodelling was of particular interest given the previous efforts of our research group to 
establish the mechanisms that promote the progression from NAFLD to NASH phenotypes 
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(Lo et al., 2011), along with possible interventions that could reverse this process. Similar to 
adipose tissue, in the liver inflammation and fibrosis are tightly regulated (Williams et al., 
2013). In contrast to the findings in adipose tissue and skeletal muscle, END was more 
effective at reversing increases in mRNA levels of Cxcl10 which has been previously 
associated with liver inflammation in humans (Zhang et al., 2014), along with normalization 
of collagen I protein levels. This may be explained by potential fuel utilization shifts that 
occur in muscle when exercise is performed at different intensities. In this context, fat 
oxidation is particularly present at moderate intensities (van Loon et al., 2001), similar to the 
END protocol, whereas at higher intensities glucose oxidation increases. These shifts in fuel 
source could be particularly beneficial for the liver during a HFD regimen, because during 
moderate intensity exercises, skeletal muscle preferentially use the lipids that are highly 
present due to HFD, relieving some of the excess fat storage in the liver. In contrast, high 
intensity exercises, such as HIIT, could promote an increase in glucose utilization without 
inducing major changes in lipid oxidation, thus having a lesser beneficial effect on liver fat 
storage. 
 
Overall, these data suggest that exercise at different intensities is able to induce similar 
metabolic benefits in highly metabolically active tissues, such as skeletal muscle, white 
adipose tissue and liver. However, high and moderate intensity exercise induce specific 
metabolic adaptations in these tissues. These findings could assist in the development of 
effective and efficient strategies to counter specific obesity-related metabolic impairments in 
the obese population, which is particularly relevant knowing that the obesity phenotype is 
highly variable in humans (Chen et al., 2015). A summary of the treatment effects of END 
and HIIT is shown in figure 8.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
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Figure 9. Summary of treatment effects of constant-moderate endurance (END) and high-
intensity interval training (HIIT) in high-fat diet fed mice. Changes specifically induced by 
END and HIIT are shown in green and blue, respectively. If both colours are present, it 
means that END and HIIT prevented that change occurring by HFD alone. 
 
7.3 Differential effects of hyperglycaemia and high-fat diet on skeletal muscle ECM 
Chapters 3 to 5 were focused on the effects of HFD on the metabolic function of skeletal 
muscle, along with the changes in other tissues that are known to have synergistic metabolic 
functions such as adipose tissue and liver. Skeletal muscle structure is known to be a plastic 
component of this tissue, that adapts accordingly depending on different levels of mechanical 
loads (Coffey and Hawley, 2007). Traditionally, the studies on skeletal muscle structure have 
focused on their contractile function attributed to the interaction of actin and myosin during 
hypertrophy and atrophy in different clinical contexts (Rodriguez et al., 2014). For optimal 
mechanical function, skeletal muscle requires the proper transmission of the force produced 
at the sarcomere to the joints and bones for movement. The extracellular matrix plays a key 
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role for this purpose (Gillies and Lieber, 2011, Sanes, 2003). This structure, mainly 
composed of fibrillar and network collagens, along with growth factors (e.g. CTGF/CCN2 
and TGFβ), proteoglycans, matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs 
(TIMPs), undergoes coordinated changes with intracellular proteins where different 
mechanical loads are imposed to muscles (Kaasik et al., 2011) to prevent contraction-derived 
damage. Considering the relevance of skeletal muscle ECM to its physiology, there is a 
notable lack of studies on this matter in a metabolic disease context. Moreover, to our 
knowledge there has been only one study that has compared skeletal muscle ECM 
composition across healthy, obese, and people with diabetes (Berria et al., 2006), finding 
higher levels of collagen and hydroxyproline in the vastus lateralis of patients with insulin-
resistance. The field has been advancing to investigate the effects of obesity and insulin-
resistance on skeletal muscle ECM and its interaction with genetic manipulations (e.g. 
integrin, thrombospondin 1, and MMP9 KO mice) (Kang et al., 2011, Kang et al., 2014, 
Inoue et al., 2013) and pharmacologic interventions (Kang et al., 2013). 
  
Nevertheless, there have been no comprehensive studies regarding the effects of different 
features of metabolic disease on skeletal muscle ECM. Thus chapter 6 in this work focused 
on characterising the effects of hyperglycaemia and HFD on skeletal muscle ECM along with 
several of its regulators. For this purpose, C57BL/6 mice were considered given that this 
strain does not readily develop hyperglycaemia spontaneously through HFD consumption, 
allowing comparisons with other animals where hyperglycaemia can be pharmacologically 
induced (e.g. low-dose streptozotocin) under a normal CHOW diet (Carvalho et al., 2018, Lo 
et al., 2011, Glastras et al., 2016). We found clear differences after chronic exposure to HFD 
and hyperglycaemia in the quadriceps ECM, where only hyperglycaemia induced a global 
increase in the collagen protein levels, a sign of ECM accumulation, whereas HFD mainly 
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induced decreases in ECM regulators without major changes in collagen levels. Moreover, 
hyperglycaemia induced a significant increase in the protein levels of pro-fibrotic factors 
such as CTGF/CCN2 as a growth factor, and TIMP1 as an inhibitor of MMPs (figure 9).  
 
 
Figure 10. Summary of the different effects of hyperglycaemia and high-fat diet on the 
skeletal muscle extracellular matrix. MMP: matrix metalloproteinase; TIMP: tissue inhibitor 
of MMP; CTGF: connective tissue growth factor; SOD: superoxide dismutase. 
 
Interestingly, a similar pattern of these proteins was found in previous work from this group 
in human renal mesangial cells, where high glucose concentration as well as matrix bound 
advance glycated end products (AGEs) non-enzymatically induced CTGF/CCN2 and TIMP1 
and increased fibronectin levels, both signs of ECM accumulation (Wang et al., 2011). 
Significant increases in AGEs have been previously described in streptozotocin-induced 
hyperglycaemic mouse soleus, tibialis anterior, and gastrocnemius (Chiu et al., 2016), 
highlighting AGEs as possible mediators of this differential effect of hyperglycaemia on 
skeletal muscle ECM. Nevertheless, it seems that collagen accumulation is not the only 
process by which metabolic impairments induce muscle dysfunction, given that this condition 
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was also found in HFD animals. It is possible that the changes in ECM regulators seen in 
obese mice, could hinder the quality of the skeletal muscle ECM, particularly in terms of the 
positioning of the different ECM layers in muscle. This is plausible considering the 
significant fat infiltration found in the quadriceps of mice after 30 weeks of HFD (Figure 10), 
which significantly disturbs the proper alignment of the ECM layers, a feature that is known 
to be necessary for the proper force transmission from the sarcomere to tendons, joint, and 
bones (Gillies and Lieber, 2011). This potential adverse mechanism of obesity and diabetes in 
skeletal muscle requires further exploration. 
 
 
Figure 11. Representative cross-sectional images stained with Picrosirius Red of quadriceps 
muscles after the interventions described in Chapter 6. A: Chow control; B: streptozotocin-
induced diabetic; C: high-fat fed; D: combination of streptozotocin-induced diabetic and 
high-fat diet. Size bars indicate 100μm and images are at 10X magnification. 
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7.4 Strengths and limitations of this work 
This work is one of the first to describe the differential metabolic effects of two different yet 
theoretically isocaloric aerobic exercise programs in a diet-induced animal model of obesity. 
In order to achieve a fair comparison between these programs, a maximal running capacity 
test was conducted in all animals. This was to measure individual aerobic capacity and 
therefore, prescribe intensities that met physiological standards. Also, both exercise regimens, 
END and HIIT, were matched in terms of distance covered in each session, and duration of 
each session, ruling out these parameters as potential confounding factors. Moreover, to 
ensure that the responses analysed were derived from chronic effects of exercise, samples 
were collected no earlier than 72 hours after the last exercise session. Considering that 
skeletal muscles with different mechanical and metabolic properties respond in a differing 
way to exercise and diet (as described in Chapter 4), quadriceps muscle was selected to 
compare the preventive (Chapters 3 and 4) and treatment (Chapter 5) effects of END and 
HIIT. In all individual experiments, all animals were housed in the same facility and animal 
room (Charles Perkins Centre animal house for chapters 3 to 5, and Royal Prince Alfred 
Hospital animal house for Chapter 6), which helps to rule out variability derived from 
different housing conditions (e.g. cage size, bedding, environmental enrichment). 
Furthermore, the high-fat diet used in all experiments was made from the same recipe, 
maintaining consistency across experiments. Male mice were selected in all experiments to 
rule out the intrinsic endocrine variations present in female mice during fertile ages and 
potential effects of the oestrus on outcomes. 
 
Limitations of this study include that only male mice were studied in this work, therefore no 
gender specific assumptions can be made from the data collected here. Moreover, only 
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aerobic exercise programs were implemented, and the metabolic effects of resistance exercise 
were not considered and should be implemented in the future, considering previous studies 
that have described potential additive effects of mixed exercise programs (aerobic + 
resistance). No differentiation of muscle fat source was made (muscle cells vs intramuscular 
adipose tissue) and should be explored in the future. Comparative studies of adipose vs 
muscle-derived adiponectin were not conducted due to lack of adipose tissue samples, 
considering that the exercise experiments (Chapters 3 to 5) were conducted in collaboration 
with another former PhD student (Dr. Babu Maharjan), who utilised most of the white and 
brown adipose tissue samples for his thesis. Given that most of the studies presented here 
described the effects of different interventions on animals (e.g. high-fat diet, exercise, 
hyperglycaemia) and raised several candidates as mediators of these responses, mechanistic 
studies that aim to confirm these hypotheses such as the role of skeletal muscle adiponectin, 
acting in a paracrine/autocrine manner, are required. 
 
7.5 Future directions 
1. Considering that in this work only aerobic exercise programs were used, the utility of 
resistance training on improving the metabolic health of insulin-sensitive tissues, 
particularly of skeletal muscles during obesity is an interesting area to be explored. 
Resistance training induces profound structural and functional changes in healthy 
skeletal muscles, where some of their most well-described changes are muscle 
hypertrophy and increased ability to produce force. To achieve this, skeletal muscles 
fibre type shift from aerobic to more glycolytic cells, changing the metabolic profile 
of this tissue. Considering that one of the main findings of this work is that exercise-
related muscle adaptations depend on muscle type/activity, comparisons between 
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different training programs (aerobic vs resistance) could shed some light on the 
specificity of the changes described here, along with possible additive effects of these 
different training types under obese conditions. 
2. All the results presented here are from metabolic adaptations of mice to high-fat diet, 
hyperglycaemia, and exercise. Although animal models have several methodological 
advantages such as lower levels of inter-subject variability and easier access to tissue 
samples for analyses, there is a significant genetic distance between mice and humans. 
The replication of these studies in clinical trials is of high scientific and clinical 
relevance, given that if similar results are found, recommendations regarding obesity 
and diabetes management could be derived from these findings. In this context, 
further research could investigate the combination of altered diet together with either 
END or HIIT once obesity is established. 
3. Considering the lack of studies available in the topics covered in this work, the 
approach selected for the experiments described here was to comprehensively 
characterize the effects of dietary and exercise interventions. Consequently, several 
pathways are suggested as being responsible for the phenomenon described here. 
Further mechanistic studies are required to test the hypothesis proposed. For instance, 
muscle-specific adiponectin KO mice would be required to test if the differences seen 
between END and HIIT on the metabolic health of HFD animals are muscle-
adiponectin dependent. As a complementary approach, cell culture studies using 
exercise mimetics (i.e. AICAR) are recommended to validate the exercise-derived 
increases in muscle adiponectin induction, where culture in a high-lipids 
concentration media could mimic the HFD environment. Moreover, considering that 
the changes described in skeletal muscle ECM of diabetic mice seem to be dependent 
on the induction of CTGF/CCN2, muscle-specific CTGF/CCN2 KO mice are needed 
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to test this hypothesis. Blocking this protein (e.g. siRNA) in cell culture in a high-
glucose media could help test the hypothesis presented here. 
4. In this work, specific pathways were of interest, such as skeletal muscle adiponectin 
induction derived from diet and exercise, skeletal muscle ECM remodelling by HFD 
and hyperglycaemia, white adipose tissue inflammation, fibrosis, and browning by 
HFD and particularly by different exercise types, along with HFD-derived NAFLD 
and its corresponding ECM remodelling. Broader approaches through the utilization 
of modern technologies such as proteomics, lipidomics, and RNA sequencing have 
shown utility in the last decade. These approaches are particularly helpful in the 
search for new mediators and biomarkers responsible for the processes investigated 
here. Therefore, considering the lack of studies particularly in the field of different 
exercise interventions on modulating metabolic impairments derived from obesity, 
proteomic and lipidomic studies on the samples extracted in the experiments 
described here are recommended, given that they could shed insights in the search of 
novel exercise mediators and biomarkers. These outcomes are specially needed in a 
field where the understanding of the mechanisms behind the metabolic benefits of 
exercise, in the context of obesity and insulin resistance, and the discovery of 
biomarkers associated with higher/lower susceptibility to the action of exercise has 
been recently increasing. 
5. In future studies, both genders should be included, given that there might be gender-
specific variations and/or responses to HFD and the different types of exercise. 
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7.6 Conclusion 
1. From a prevention perspective, END and HIIT confer similar metabolic adaptations in 
terms of insulin sensitivity and muscle function in high-fat diet fed mice. However, 
END is more effective in preventing hyperglycaemia and hyperinsulinaemia derived 
from high-fat diet intake. These differential changes might be related to the higher 
efficiency of END at inducing HMW muscle adiponectin compared to HIIT, changes 
that were associated with normalization of mRNA levels of downstream factors of 
adiponectin in quadriceps. 
2. Skeletal muscle adiponectin induction is not a homogenous process across skeletal 
muscles, given that this process seems to be dependent on diet and muscle 
type/activity. High-fat diet decreases more bioactive isoforms (HMW) of adiponectin 
in muscle with higher oxidative fibres (quadriceps), whereas in more glycolytic 
muscles (gastrocnemius) there is an increase in less bioactive isoforms, probably as a 
protective mechanism against an increase in fat influx. Interestingly, HMW muscle 
adiponectin was only present in exercised muscles, given that in masseter muscles it 
was not found, suggesting that this isoform is highly dependent on the levels of 
muscle activity. 
3. From a treatment perspective, END and HIIT does not have a significant impact on 
body weight or body composition if HFD is consumed while the exercise regimens 
are being performed. However, both exercise regimens induce comparable metabolic 
benefits in insulin-sensitive tissues. For instance, both END and HIIT normalise 
muscle adiponectin profiles, reduce inflammation and fibrosis markers in white 
adipose tissue, and signs of steatosis in the liver. Interestingly, HIIT showed better 
efficiency in normalising systemic insulin sensitivity, which might be related to 
normalization of muscle adiponectin receptors and increase markers of browning in 
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white adipose tissue. Moreover, END exhibits better effects for normalizing plasma 
triglycerides and reducing inflammatory and fibrosis markers in the liver. This 
suggests that even when END and HIIT were isocaloric, they can induce differential 
metabolic benefits in a tissue-specific manner. 
4. Skeletal muscle ECM is disturbed after long-term systemic hyperglycaemia and high-
fat diet intake, however the direction of changes and the components affected differs 
between these two conditions. Systemic hyperglycaemia increases several types of 
collagen (-I, -IV, -VI) in skeletal muscle, changes that are accompanied by increases 
in CTGF/CCN2 and TIMP1 protein. Chronic HFD intake does not change collagen 
levels in quadriceps, however it decreases the protein levels of several ECM 
regulators, such as CTGF/CCN2, MMP1, and TIMP2. Interestingly, both 
interventions induced skeletal muscle dysfunction by decreasing its ability to produce 
force. 
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7.7 Final conclusion 
Overall, the experiments performed in this thesis confirm the hypothesis that skeletal muscle 
is susceptible to a decrease in its function during obese and diabetes conditions, by impairing 
its structure and metabolic function. Our findings confirm that physical exercise is able to 
prevent and/or treat some of these metabolic consequences derived from obesity. However, 
the exercise modality utilised seems to be relevant in order to achieve these effects. 
Interestingly, different exercise types, even when isocaloric, target different specific insulin-
sensitive tissues to differing degrees, suggesting that physical exercise could be tailored to 
help target specific metabolic impairments present in obese subjects. Further preclinical 
mechanistic and clinical studies are indicated to build upon these findings, and to help realise 
personalised medicine approaches to exercise in people with metabolic disease. 
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